[424B3] Innventure, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Innventure, Inc. filed a prospectus registering the resale of up to 24,250,470 shares of common stock by selling stockholders. The registration covers (i) up to 12,000,000 shares issuable upon conversion of Yorkville-held convertible debentures, (ii) up to 9,000,000 shares that may be issued and sold to Yorkville under the Standby Equity Purchase Agreement (SEPA), each subject to ownership limits, and (iii) 3,250,470 shares from October 2025 subscription agreements, including 1,625,235 already issued and 1,625,235 issuable upon exercise of Series A Warrants.
Innventure will not receive proceeds from stockholder resales. The company may receive up to approximately $67.0 million in remaining aggregate gross proceeds from future SEPA sales to Yorkville and de minimis proceeds from any cash exercises of the Series A Warrants. Shares outstanding were 58,046,433 as of October 14, 2025.
Positive
- None.
Negative
- None.
TABLE OF CONTENTS
TABLE OF CONTENTS
Page | |||
ABOUT THIS PROSPECTUS | ii | ||
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS | iv | ||
PROSPECTUS SUMMARY | 1 | ||
RISK FACTORS | 12 | ||
USE OF PROCEEDS | 31 | ||
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 32 | ||
BUSINESS | 49 | ||
MANAGEMENT | 64 | ||
EXECUTIVE AND DIRECTOR COMPENSATION OF INNVENTURE | 70 | ||
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS | 78 | ||
DESCRIPTION OF SECURITIES | 87 | ||
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 92 | ||
SELLING STOCKHOLDERS | 95 | ||
SHARES ELIGIBLE FOR FUTURE SALE | 98 | ||
PLAN OF DISTRIBUTION | 100 | ||
EXPERTS | 101 | ||
LEGAL MATTERS | 102 | ||
WHERE YOU CAN FIND MORE INFORMATION | 102 | ||
INDEX TO FINANCIAL STATEMENTS | F-1 | ||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | expectations regarding Innventure’s and the Innventure Companies’ (as defined below) ability to execute on strategies and achieve future financial performance, including their respective future business plans, expansion and acquisition plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and Innventure’s ability to invest in growth initiatives; |
• | the implementation, market acceptance and success of Innventure’s and the Innventure Companies’ business models and growth strategies; |
• | Innventure’s and the Innventure Companies’ future capital requirements and sources and uses of cash; |
• | sustained unfavorable economic or other conditions which could cause the need for Innventure to evaluate and potentially record additional impairment charges for all, or a portion of, its goodwill and other intangible assets; |
• | Innventure’s future capital requirements and sources and uses of cash, including: (i) Innventure’s ability to obtain funding for its operations and future growth; and (ii) Innventure’s ability to continue as a going concern; |
• | Innventure’s ability to maintain control over the Innventure Companies; |
• | Innventure’s ability to meet the various conditions imposed by, and to satisfy its obligations to, the WTI Lenders (as defined below), under the WTI Facility (as defined below); |
• | Innventure’s access to funds under the SEPA (as defined herein) with Yorkville, including ownership limitations, issuances and subscriptions based on trading volumes, and Innventure’s ability to continue to access the funds available under the SEPA or the Securities Purchase Agreement and related, unissued New Convertible Debentures due to certain conditions, restrictions and limitations set forth therein; |
• | certain restrictions and limitations set forth in Innventure’s debt instruments, which may impair Innventure’s financial and operating flexibility; |
• | Innventure’s and the Innventure Companies’ ability to generate liquidity and maintain sufficient capital to operate as anticipated; |
TABLE OF CONTENTS
• | Innventure’s and the Innventure Companies’ ability to obtain funding for their operations, future growth and to continue as going concerns; |
• | the risk that the technology solutions that Innventure and the Innventure Companies license or acquire from third parties or develop internally may not function as anticipated or provide the benefits anticipated; |
• | developments and projections relating to Innventure’s and the Innventure Companies’ competitors and industry; |
• | the ability of Innventure and the Innventure Companies to scale the operations of their respective businesses; |
• | the ability of Innventure and the Innventure Companies to establish substantial commercial sales of their products; |
• | the ability of Innventure and the Innventure Companies to compete against companies with greater capital and other resources or superior technology or products; |
• | Innventure and the Innventure Companies’ ability to meet, and to continue to meet, applicable regulatory requirements for the use of their respective products and the numerous regulatory requirements generally applicable to their businesses; |
• | the outcome of any legal proceedings against Innventure or the Innventure Companies; |
• | Innventure’s ability to find future opportunities to license or acquire breakthrough technology solutions from MNCs (as defined below) or other third parties (collectively, “Technology Solutions Providers”) and to satisfy the requirements imposed by or to avoid disagreements with its current and future Technology Solutions Providers; |
• | the risk that the launch of new companies distracts Innventure’s management from its subsidiaries and their respective operations; |
• | the risk that Innventure may be deemed an investment company under the Investment Company Act of 1940 (the “Investment Company Act”), which would impose burdensome compliance requirements and restrictions on its activities; |
• | Innventure’s ability to sufficiently protect the intellectual property (“IP”) rights of itself and its Operating Companies, and to avoid or resolve in a timely and cost-effective manner any disputes that may arise relating to its use of the IP of third parties; |
• | the risk of a cyber-attack or a failure of Innventure’s information technology and data security infrastructure; |
• | geopolitical risk and changes in applicable laws or regulations, including with respect to foreign trade policy and tariffs; |
• | potential adverse effects of other economic, business, and/or competitive factors; |
• | operational risks related to Innventure and the Innventure Companies, which have limited or no operating history; and |
• | the limited liquidity and trading of Innventure’s securities. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | Ownership Limitation: Yorkville shall not purchase or acquire any shares of Common Stock pursuant to the SEPA that would result in it and its affiliates (on an aggregated basis) beneficially owning more than 9.99% of the then outstanding voting power or number of shares of Common Stock; |
• | Registration Limitation: In no event shall an Advance exceed the amount of shares of Common Stock registered under an effective registration statement that provides for the resale from time to time of the shares of Common Stock sold pursuant the SEPA; |
• | Volume Limitation: In certain instances, if the total number of Common Stock traded on NASDAQ during the applicable period is less than a specified threshold, then the number of shares issued and sold by the Company under the Advance will be limited to the greater of (a) 35% of the trading volume during the applicable period or (b) the number of shares of Common Stock sold by Yorkville during the applicable period (in each case not to exceed the amount specified in the Advance and the other limitations under the SEPA); and |
• | Minimum Acceptable Price: If the Company notifies Yorkville of a minimum acceptable price (“MAP” as defined in the SEPA), then, if during the applicable period the VWAP of the Common Stock is below the specified MAP or there is no VWAP, the amount of Common Stock set forth in the Advance will be reduced by one third (1/3rd); provided, however, that this lower amount may be increased if certain conditions are met. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | Innventure may not be able to obtain additional financing to fund the operations and growth of the business. |
• | There is uncertainty regarding Innventure’s ability to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt about its ability to continue as a going concern. |
• | Innventure’s principal revenues are expected to be earned in the future through its Operating Companies, including through AeroFlexx, Accelsius and Refinity, and Innventure depends on its Operating Companies for cash. |
• | Innventure may not be successful in finding future opportunities to license or acquire breakthrough technology solutions from Technology Solutions Providers. |
• | The Innventure Companies are currently early commercial stage companies that may never achieve or sustain profitability. |
• | If Innventure or the Innventure Companies are not able to satisfy the requirements imposed by technology providers or have disagreements with those technology providers, their relationships with these partners could deteriorate, which could have a material adverse effect on the business of Innventure and the Innventure Companies. |
• | The WTI Facility may impair Innventure LLC’s, Innventure’s and the Operating Companies’ financial and operating flexibility. |
• | It is not possible to predict the extent to which Innventure will, intends to, or may rely on Yorkville and the SEPA as a source of funding. |
• | It is not possible to predict the actual number of shares Innventure will sell under the SEPA or issue under the Convertible Debentures to Yorkville, or the actual gross proceeds resulting from those sales, if applicable. |
• | Innventure’s pursuit of new business strategies and acquisitions could disrupt its ongoing business, present risks not originally contemplated and materially adversely affect its business, reputation, results of operations and financial condition. |
• | The market price of our Common Stock is likely to be highly volatile, and you may lose some or all of your investment. |
• | Volatility in Innventure’s share price could subject Innventure to securities class action litigation. |
• | Future sales of shares of our Common Stock or other equity may depress its stock price. |
• | Provisions in our Amended and Restated Certificate of Incorporation (the “A&R Certificate of Incorporation”) and under Delaware law could discourage a takeover that stockholders may consider favorable and may lead to entrenchment of management. |
• | Innventure is an emerging growth company and smaller reporting company, and Innventure cannot be certain if the reduced reporting requirements applicable to emerging growth companies and smaller reporting companies will make its shares less attractive to investors. |
• | Future offerings of debt or offerings or issuances of equity securities by the Innventure may adversely affect the market price of the Common Stock or otherwise dilute all other stockholders. |
• | If Innventure’s estimates or judgments relating to its critical accounting estimates prove to be incorrect or financial reporting standards or interpretations change, Innventure’s results of operations could be adversely affected. |
TABLE OF CONTENTS
• | The Company has identified material weaknesses in its internal controls over financial reporting that could, if not remediated, result in material misstatements in its financial statements and which may have an impact on Innventure’s ability to timely or accurately report its financial condition or results of operations following the consummation of the Business Combination. |
• | If Innventure is deemed to be an investment company under the Investment Company Act, it may be required to institute burdensome compliance requirements and its activities may be restricted, which may make it difficult to operate or to execute its growth plans. |
• | AFX, Accelsius and Refinity are early-stage companies, and their limited operating histories makes it difficult to evaluate their future prospects and the risks and challenges they may encounter. |
• | Accelsius’ cooling products may be subject to increased regulatory scrutiny due to their use of working fluid refrigerants that contain fluorine. |
• | The market, including customers and potential investors, may be skeptical of the viability and benefits of Accelsius’ cooling products and Refinity’s plastic waste recycling process because they are based on relatively novel and complex technology. |
• | The failure of AFX’s suppliers to continue to deliver necessary raw materials or other components of its products in a timely manner and to specification could prevent it from delivering products within required time frames and could cause production delays, cancellations, penalty payments and damage to its brand and reputation. |
• | AFX may not be able to meet applicable regulatory requirements for the use of AFX’s products in food grade applications, and, even if the requirements are met, complying on an ongoing basis with the numerous regulatory requirements applicable to AFX’s products and AFX’s facilities will be time-consuming and costly. |
• | Innventure may be unable to sufficiently protect the IP rights of itself and the Innventure Companies and may encounter disputes from time to time relating to its use of the IP of third parties. |
• | Innventure, the Innventure Companies, and Innventure’s MNC partners may be negatively impacted by volatility in the political and economic environment, such geopolitical unrest, economic downturns and increases in interest rates, and a period of sustained inflation, which could have an adverse impact on Innventure’s and the Innventure Companies’ business, financial condition, results of operations and prospects. |
• | Changes in U.S. or foreign trade policies, including additional tariffs or global trade conflicts, may adversely impact our business and operating results. |
• | Cyber-attacks or a failure in Innventure’s information technology and data security infrastructure could adversely affect Innventure’s business and operations. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | develop and commercialize their products and processes; |
• | design and deliver products and processes of acceptable performance that function as anticipated; |
• | increase sales revenue; |
• | forecast their revenue and budget for and manage their expenses; |
• | attract new customers and commercial relationships; |
• | compete successfully in the industry in which they operate; |
• | plan for and manage capital expenditures for their current and future products and manage their supply chain and supplier relationships related to their current and future products; |
• | scale quickly enough due to capital and other resource constraints; |
• | find, contract with, and retain reliable and commercially reasonable materials, components, manufacturers and inventory vendors; |
• | comply with existing and new or modified laws and regulations applicable to their business in and outside the United States, including compliance requirements of U.S. customs and export regulations; |
TABLE OF CONTENTS
• | anticipate and respond to macroeconomic changes and changes in the markets in which they operate; |
• | anticipate and respond to regulatory and/or environmental policies that impact the Innventure Companies’ plant operations; |
• | maintain and enhance the value of their reputation and brand; |
• | develop and protect IP; |
• | hire, integrate and retain talented people at all levels of their organizations; |
• | successfully defend themselves in any legal proceeding that may arise and enforce their rights in any legal proceedings they may initiate; and |
• | manage and mitigate the adverse effects on their business of any public health emergencies, natural disasters, widespread travel disruptions, security risks including IT security, data privacy, cyber risks, international conflicts, geopolitical tension and other events beyond their control. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | actual or anticipated fluctuations in Innventure’s financial condition and operating results, including fluctuations in its quarterly and annual results; |
• | developments involving Innventure’s competitors; |
• | changes in laws and regulations affecting Innventure’s business; |
• | variations in Innventure’s operating performance and the performance of its competitors in general; |
• | the public’s reaction to Innventure’s press releases, its other public announcements and its filings with the SEC; |
• | additions and departures of key personnel; |
• | announcements of significant acquisitions, strategic partnerships, joint ventures or capital commitments by Innventure or its competitors; |
• | Innventure’s failure to meet the estimates and projections of the investment community or that it may otherwise provide to the public; |
• | publication of research reports about Innventure’s industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts; |
• | changes in the market valuations of similar companies; |
• | overall performance of the equity markets; |
• | sales of the Common Stock or preferred stock by Innventure or its stockholders in the future; |
• | trading volume of the Common Stock; |
• | significant lawsuits, including shareholder litigation; |
• | failure to comply with the requirements of NASDAQ; |
• | general economic, industry and market conditions other events or factors, many of which are beyond Innventure’s control; and |
• | changes in accounting standards, policies, guidelines, interpretations or principles. |
TABLE OF CONTENTS
• | a classified board of directors with three-year staggered terms, which may delay the ability of stockholders to change the membership of a majority of the Board; |
• | no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates; |
• | the exclusive right of the Board, unless the Board grants such a right to the holders of any series of preferred stock, to elect a director to fill a vacancy created by the expansion of the Board or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our Board; |
• | the prohibition on removal of directors without cause; |
• | the ability of the Board to authorize the issuance of shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer; |
TABLE OF CONTENTS
• | the ability of the Board to alter the Bylaws without obtaining stockholder approval; |
• | the required approval of at least 2/3 of the shares entitled to vote to amend or repeal the Bylaws or amend, alter or repeal certain provisions of the A&R Certificate of Incorporation; |
• | a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of Innventure’s stockholders; |
• | an exclusive forum provision providing that the Court of Chancery of the State of Delaware (the “Delaware Court”) will be the exclusive forum for certain actions and proceedings; |
• | the requirement that a special meeting of stockholders may be called only by the Board, Innventure’s chief executive officer, or the chairman of the Board, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; |
• | advance notice procedures that stockholders must comply with in order to nominate candidates to the Board or to propose matters to be acted upon at a stockholders’ meeting, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of Innventure; and |
• | Innventure is subject to the anti-takeover provisions contained in Section 203 of the Delaware General Corporation Law, which will prevent Innventure from engaging in a business combination with any holder of 15% or more of its capital stock unless the holder has held the stock for three years or, among other exceptions, the Board has approved the transaction. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | restrictions on the nature of its investments; |
• | limitations on its ability to borrow; |
• | prohibitions on transactions with affiliates; and |
• | restrictions on the issuance of securities. |
• | registration as an investment company and subsequent regulation as an investment company; |
• | adoption of a specific form of corporate structure; and |
• | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Successor | Predecessor | |||||||||||
Six months ended June 30, 2025 | Six months ended June 30, 2024 | Change | ||||||||||
($) | ($) | ($) | ($) | |||||||||
Revenue | $700 | $447 | $253 | 56.6% | ||||||||
Operating Expenses | ||||||||||||
Cost of Sales | 3,045 | –– | 3,045 | nm* | ||||||||
General and administrative | 38,245 | 16,283 | 21,962 | 134.9% | ||||||||
Sales and marketing | 4,304 | 2,549 | 1,755 | 68.9% | ||||||||
Research and development | 12,321 | 3,433 | 8,888 | 258.9% | ||||||||
Goodwill impairment | 346,557 | –– | 346,557 | nm* | ||||||||
Total Operating Expenses | 404,472 | 22,265 | 382,207 | 1,716.6% | ||||||||
Loss from Operations | (403,772) | (21,818) | (381,954) | 1,750.6% | ||||||||
Non-operating (Expense) and Income | ||||||||||||
Interest expense, net | (4,185) | (448) | (3,737) | 834.2% | ||||||||
Net gain (loss) on investments | –– | 4,399 | (4,399) | (100.0)% | ||||||||
Net gain (loss) on investments – due to related parties | –– | (160) | 160 | (100.0)% | ||||||||
Change in fair value of financial liabilities | 23,605 | (478) | 24,083 | (5,038.3)% | ||||||||
Equity method investment (loss) income | (8,680) | 784 | (9,464) | (1,207.1)% | ||||||||
Realized gain on conversion of available for sale investment | 1,507 | –– | 1,507 | nm* | ||||||||
Loss on extinguishment of related party debt | (3,538) | –– | (3,538) | nm* | ||||||||
Loss on extinguishment of debt | (3,462) | –– | (3,462) | nm* | ||||||||
Loss on conversion of promissory notes | –– | (1,119) | 1,119 | (100.0)% | ||||||||
Miscellaneous other expense | (43) | –– | (43) | nm* | ||||||||
Total Non-operating (Expense) Income | 5,204 | 2,978 | 2,226 | 74.7% | ||||||||
Income tax benefit | (3,619) | –– | (3,619) | nm* | ||||||||
Net Loss | (394,949) | (18,840) | (376,109) | 1,996.3% | ||||||||
Less: net loss attributable to Non-redeemable non-controlling interest | (167,725) | (6,333) | (161,392) | 2,548.4% | ||||||||
Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | (227,224) | (12,507) | (214,717) | 1,716.8% | ||||||||
Other comprehensive income, net of taxes: | ||||||||||||
Unrealized gain (loss) on available for sale debt securities – related party | (691) | –– | (691) | nm* | ||||||||
Reclassification of realized gain on conversion of available for sale investments | (1,507) | –– | (1,507) | nm* | ||||||||
Total other comprehensive income, net of taxes | (2,198) | — | (2,198) | nm* | ||||||||
Total comprehensive loss, net of taxes | (397,147) | (18,840) | (378,307) | 2,008.0% | ||||||||
Less: comprehensive loss attributable to Non-redeemable non-controlling interest | (167,725) | (6,333) | (161,392) | 2,548.4% | ||||||||
Net Comprehensive Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | $(229,422) | $(12,507) | $(216,915) | 1,734.3% | ||||||||
* | not meaningful |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Three months ended | Six months ended | |||||||||||
June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||
Net loss | $(141,275) | $(11,314) | $(394,949) | $(18,840) | ||||||||
Interest expense, net(1) | 2,647 | 43 | 4,185 | 448 | ||||||||
Depreciation and amortization expense | 5,634 | 64 | 11,182 | 69 | ||||||||
Income tax benefit | (2,220) | — | (3,619) | — | ||||||||
EBITDA | (135,214) | (11,207) | (383,201) | (18,323) | ||||||||
Transaction and other related costs(2) | — | 2,769 | — | 6,041 | ||||||||
Change in fair value of financial liabilities(3) | (7,176) | — | (23,605) | 478 | ||||||||
Stock-based compensation(4) | 9,406 | 293 | 15,247 | 689 | ||||||||
Goodwill impairment(5) | 113,344 | — | 346,557 | — | ||||||||
Loss on extinguishment of debt(6) | 3,462 | — | 3,462 | — | ||||||||
Loss on extinguishment of related party debt(7) | — | — | 3,538 | — | ||||||||
Loss on conversion of promissory notes | — | — | — | 1,119 | ||||||||
Adjusted EBITDA | $(16,178) | $(8,145) | $(38,002) | $(9,996) | ||||||||
(1) | Interest Expense, net, includes interest incurred on our various borrowing facilities and the amortization of debt issuance costs. |
(2) | Transaction and other related costs – For the three and six months ended June 30, 2024 (Predecessor), this is comprised of consulting, legal, and other professional fees related to the Business Combination. |
(3) | Change in fair value of financial liabilities – For the three and six months ended June 30, 2025 (Successor), the change in fair value of financial liabilities primarily consists of the change in fair value of the warrant liability and the earnout liability. For the three and six months ended June 30, 2024 (Predecessor), this is comprised entirely of the change in fair value of the embedded derivative associated with the convertible notes. |
(4) | Stock based compensation – For the three and six months ended June 30, 2025 (Successor), stock based compensation primarily consisted of awards in the 2024 Equity and Incentive Plan entered into on October 2, 2024 subsequent to the Business Combination. These awards consisted of Stock Options, Restricted Stock Units (“RSUs”), and Stock Appreciation Rights. Further, a portion of this expense was related to share-based payment employee incentive plans in existence at Innventure LLC and other subsidiaries. Additional Stock Options were granted in February 2025 and additional RSUs were granted in June 2025 which are included in the stock-based compensation caption for their respective periods. For the three and six months ended June 30, 2024 (Predecessor), stock-based compensation was comprised wholly of share-based payment employee incentive plans in existence at Innventure LLC and other subsidiaries. |
(5) | Goodwill impairment - For the three and six months ended June 30, 2025 (Successor), the Company recognized goodwill impairment due to sustained decreases in the Company’s publicly quoted share price and market capitalization, which were, at least in part, sensitive to the general downward volatility experienced in the stock market from late February 2025 through April 2025. The publicly quoted share price stabilized some in May 2025 and June 2025. There was no similar goodwill impairment charge for the three and six months ended June 30, 2024 (Predecessor). |
(6) | Loss on extinguishment of debt - For the three and six months ended June 30, 2025 (Successor), the Company modified the WTI Facility, and such modification was accounted for as a debt extinguishment while no debt was repaid. There was no loss on extinguishment of debt for the three and six months ended June 30, 2024 (Predecessor). |
(7) | Loss on extinguishment of related party debt - For the three and six months ended June 30, 2025 (Successor), the Company extinguished certain related party debts by issuing Series C Preferred Stock. There was no loss on extinguishment of related party debt for the three and six months ended June 30, 2024 (Predecessor). |
TABLE OF CONTENTS
Successor | Predecessor | S/P Combined (Non-GAAP) | Predecessor | Non-GAAP | ||||||||||||||
Period from October 2, 2024 through December 31, 2024 | Period from January 1, 2024 through October 1, 2024 | Year ended December 31, 2024 | Year ended December 31, 2023 | 2024 vs 2023 Changes | ||||||||||||||
($) | ($) | ($) | ($) | ($) | (%) | |||||||||||||
Revenue | 456 | 764 | 1,220 | 1,117 | 103 | 9.2% | ||||||||||||
Operating Expenses | ||||||||||||||||||
Cost of sales | 3,752 | 777 | 4,529 | — | 4,529 | nil | ||||||||||||
General and administrative | 29,652 | 26,608 | 56,260 | 17,589 | 38,671 | 219.9% | ||||||||||||
Sales and marketing | 2,009 | 4,178 | 6,187 | 3,205 | 2,982 | 93.0% | ||||||||||||
Research and development | 5,340 | 5,978 | 11,318 | 4,001 | 7,317 | 182.9% | ||||||||||||
Total Operating Expenses | 40,753 | 37,541 | 78,294 | 24,795 | 53,499 | 215.8% | ||||||||||||
Loss from Operations | (40,297) | (36,777) | (77,074) | (23,678) | (53,396) | 225.5% | ||||||||||||
Non-operating (Expense) and Income | ||||||||||||||||||
Interest expense, net | (1,132) | (1,300) | (2,432) | (1,224) | (1,208) | 98.7% | ||||||||||||
Net gain (loss) from investments | — | 11,547 | 11,547 | (6,448) | 17,995 | 279.1% | ||||||||||||
Net (loss) gain on investments - due to related parties | — | (468) | (468) | 232 | (700) | (301.7)% | ||||||||||||
Change in fair value of financial liabilities | (20,946) | (478) | (21,424) | 766 | (22,190) | (2,896.9)% | ||||||||||||
Equity method investment (loss) income | (902) | 893 | (9) | (632) | 623 | (98.6)% | ||||||||||||
Loss on conversion of promissory notes | — | (1,119) | (1,119) | — | (1,119) | nil | ||||||||||||
Write-off of loan commitment fee asset | (10,041) | — | (10,041) | — | (10,041) | nil | ||||||||||||
Miscellaneous other expense | (57) | (64) | (121) | — | (121) | nm* | ||||||||||||
Total Non-operating (Expense) Income | (33,078) | 9,011 | (24,067) | (7,306) | (16,761) | 229.4% | ||||||||||||
Income tax expense (benefit) | (3,282) | 432 | (2,850) | — | (2,850) | nm* | ||||||||||||
Net Loss | (70,093) | (28,198) | $(98,291) | (30,984) | (67,307) | 217.2% | ||||||||||||
Less: net loss attributable to Non-redeemable non-controlling interest | (8,339) | (11,762) | $(20,101) | (139) | (19,962) | 14,361.2% | ||||||||||||
Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | (61,754) | (16,436) | (78,190) | (30,845) | (47,345) | 153.5% | ||||||||||||
TABLE OF CONTENTS
Successor | Predecessor | S/P Combined (Non-GAAP) | Predecessor | Non-GAAP | ||||||||||||||
Period from October 2, 2024 through December 31, 2024 | Period from January 1, 2024 through October 1, 2024 | Year ended December 31, 2024 | Year ended December 31, 2023 | 2024 vs 2023 Changes | ||||||||||||||
($) | ($) | ($) | ($) | ($) | (%) | |||||||||||||
Other comprehensive income, net of taxes: | ||||||||||||||||||
Unrealized gain on available-for-sale debt securities - related party | 909 | 62 | 971 | — | 971 | nil | ||||||||||||
Total other comprehensive loss, net of taxes | 909 | 62 | $971 | — | 971 | nil | ||||||||||||
Total comprehensive loss, net of taxes | (69,184) | (28,136) | (97,320) | (30,984) | (66,336) | 214.1% | ||||||||||||
Less: comprehensive income attributable to Non-redeemable non-controlling interest | (8,339) | (11,762) | (20,101) | (139) | (19,962) | 14,361.2% | ||||||||||||
Net Comprehensive Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | (60,845) | (16,374) | (77,219) | (30,845) | (46,374) | 150.3% | ||||||||||||
* | not meaningful |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Successor | Predecessor | S/P Combined (Non-GAAP) | Predecessor | |||||||||
Period from October 2, 2024 through December 31, 2024 | Period from January 1, 2024 through October 1, 2024 | Year ended December 31, 2024 | Year ended December 31, 2023 | |||||||||
Net Loss | (70,093) | (28,198) | (98,291) | (30,984) | ||||||||
Interest expense, net(1) | 11,173 | 1,300 | 12,473 | 1,224 | ||||||||
Depreciation and amortization expense | 5,455 | 146 | 5,601 | 8 | ||||||||
Provision for income taxes | 3,282 | (432) | 2,850 | — | ||||||||
EBITDA | (50,183) | (27,184) | (77,367) | (29,752) | ||||||||
Transaction and other related costs(2) | 2,309 | 9,414 | 11,723 | 3,452 | ||||||||
Change in fair value of financial liabilities(3) | 20,946 | 478 | 21,424 | (766) | ||||||||
Stock based compensation(4) | 16,338 | 1,056 | 17,394 | 910 | ||||||||
Adjusted EBITDA | (10,590) | (16,236) | (26,826) | (26,156) | ||||||||
(1) | Interest expense, net – For the combined twelve months ended December 31, 2024, interest expense, net includes interest incurred on our various borrowing facilities and the amortization of debt issuance costs. Additional debt issuance cost associated with a loan commitment fee asset in the amount of $10,041 was written off in combined twelve months ended December 31, 2024 and has also been included in this adjustment. This amount is representative of the asset associated with the second and third tranches of the WTI facility. When it became known that we would not be able to draw on these subsequent tranches based on certain metrics contained within the WTI Facility agreement, we immediately wrote this asset off. For the Predecessor year ended December 31, 2023, this balance is comprised entirely of interest incurred on our various borrowing facilities. |
(2) | Transaction and other related costs – For the combined twelve months ended December 31, 2024 and for the Predecessor year ended December 31, 2023 this is comprised entirely of consulting, legal, and other professional fees related to the “Business Combination”. |
TABLE OF CONTENTS
(3) | Change in fair value of financial liabilities – For the combined twelve months ended December 31, 2024 the change in fair value of financial liabilities primarily consists of the change in fair value of the warrant liability, change in fair value of the earnout liability, and the change in the fair value of the embedded derivative associated with convertible notes prior to extinguishment. For the Predecessor year ended December 31, 2023, this is comprised entirely of the change in fair value of the embedded derivative associated with the convertible notes. |
(4) | Stock based compensation – For the combined twelve months ended December 31, 2024 stock based compensation primarily consisted of awards in the 2024 Equity and Incentive Compensation Plan entered into on October 2, 2024 subsequent to the Business Combination. These awards consisted of Stock Options, RSUs, and Stock Appreciation Rights. Further, a portion of this expense was related to share based payment employee incentive plans in existence at Innventure LLC and other subsidiaries. For the Predecessor year ended December 31, 2023, stock based compensation was comprised wholly of share based payment employee incentive plans in existence at Innventure LLC and other subsidiaries. |
June 30, 2025 | December 31, 2024 | |||||
Cash and cash equivalents | $6,965 | $11,119 | ||||
Working capital | (51,188) | (45,061) | ||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Successor | Predecessor | Change | ||||||||||
Six months ended June 30, 2025 | Six months ended June 30, 2024 | Amount | % Change | |||||||||
Net Cash Used in Operating Activities | $(36,754) | $(16,391) | $(20,363) | 124.2% | ||||||||
Net Cash Used in Investing Activities | (3,640) | (4,377) | 737 | (16.8)% | ||||||||
Net Cash Provided by Financing Activities. | 41,240 | 20,274 | 20,966 | 103.4% | ||||||||
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash | $846 | $(494) | $1,340 | 271.3% | ||||||||
Successor | Predecessor | S/P Combined 2024 | Predecessor | Change | ||||||||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2024 | Year ended December 31, 2023 | Amount | % Change | |||||||||||||
Net Cash Used in Operating Activities | $(29,214) | $(18,848) | $(48,062) | $(19,476) | $(28,586) | 146.8% | ||||||||||||
Net Cash Provided by (Used in) Investing Activities | 6,822 | (5,957) | 865 | (4,667) | 5,532 | 118.5% | ||||||||||||
Net Cash Provided by Financing Activities | 33,466 | 38,441 | 71,907 | 19,174 | 52,733 | 275.0% | ||||||||||||
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | $11,074 | $13,636 | $24,710 | $(4,969) | $29,679 | (597.3)% | ||||||||||||
TABLE OF CONTENTS
2025 (remaining 6 months) | 2026 | 2027 | 2028 | Thereafter | Total | |||||||||||||
Operating lease | $309 | $693 | $467 | $228 | $— | $1,697 | ||||||||||||
Debt obligations | 13,011 | 29,234 | 8,244 | 4,561 | — | 55,050 | ||||||||||||
Fixed future installments payable | 700 | 825 | 825 | 825 | 9,900 | 13,075 | ||||||||||||
Total | $14,020 | $30,752 | $9,536 | $5,614 | $9,900 | $69,822 | ||||||||||||
TABLE OF CONTENTS
TABLE OF CONTENTS

TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | Access Advantage: The relationship with an MNC provides unique access to MNC technologies and/or the information needed to help Innventure evaluate a disruptive technology solution in the context of specific unmet market needs. Using both data from the MNC and its own evaluations, Innventure determines if the opportunity should progress to a new Innventure Company. |
• | Developed Technology Solutions: MNCs invest significant time, money, and technical expertise in developing and protecting innovative technology solutions that satisfy unmet market needs for them and their customers. This all occurs well before Innventure acquires the technology solution. A new Innventure Company that sources the technology solution from an MNC—including IP such as patents and trade secrets, product prototypes, manufacturing equipment, and other assets—has access to the MNC’s technical expertise for transfer and early industrialization of the technology, all of which helps reduce commercialization time, save money, and mitigate common risks inherent to start-ups. |
• | Institutional Data Set: MNCs also spend significant time and money developing deep, proprietary market knowledge, which is very difficult for a typical new venture to replicate. MNCs are in a position to provide Innventure with highly robust data, including market insights and customer testing, to understand unmet market needs and to assess the technology solution and potential business models. |
• | Early Customer Adoption: We believe MNCs with which we collaborate will be motivated to catalyze market adoption of a technology solution by becoming early customers and/or providing channel access to facilitate the initial customer base to drive financial and strategic value. When Innventure sources technology from an entity that is not expected to be a channel partner, it seeks to establish a relationship with an MNC that will serve as a channel partner for the new company. In some cases, MNCs may choose to sign offtake agreements with the new company and/or facilitate access to prospective customers within their sphere of influence (e.g., suppliers or customers). We believe when an MNC is the original “inventor” or an early adopter of the technology solution, it may bring immediate credibility to the new Innventure Company which can lead to greater interest from potential customers. |
TABLE OF CONTENTS
• | PureCycle: Purifies and recycles post-industrial and post-consumer polypropylene waste back to a like virgin grade polymer, usable across a broad range of applications and markets. PureCycle became a publicly traded company in 2021 and, as of the date of this prospectus, Innventure no longer has an economic interest in PureCycle. |
• | AeroFlexx: Combines the best attributes of flexible pouches and rigid bottles to provide consumer packaged goods (“CPG”) companies with a novel, curbside recyclable primarily liquid package that uses up to 85% less virgin plastic than standard rigid bottles, significantly simplifies packaging supply |
TABLE OF CONTENTS
• | Accelsius: Delivers a transformative industry solution to thermal management to central processing units (“CPUs”) and graphics processing units (“GPUs”) in datacenter and telecommunications applications, with potential to allow operators to increase computational throughput and capacity, increase revenue, reduce operating costs, increase energy efficiency, and drive sustainability across server, switching, and edge computing environments. Accelsius is an early-stage company that is just beginning revenue-generating operations. Accelsius has been focused on developing and commercializing data center cooling products since its inception in 2022 and has begun generating revenue. |
• | Refinity: Intends to commercialize process technologies for converting low cost, abundant plastic waste to drop-in chemicals directly useful in and consumable by the existing petrochemical supply chain. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | an exponential predicted increase in the thermal footprint, or thermal design power (“TDP”), of server and GPU chipsets which are now beginning to exceed the capability of the incumbent refrigerated-air cooling systems; |
• | increased and unpredictable global energy costs; and |
• | an increased level of commitment to environmental sustainability, including from C-suites and corporate management teams. |
• | Components: Increased software stack (including AI) require higher performance processors which increase heat dissipation. |
• | Equipment: More powerful servers, routers, switches, cell tower base stations, and other computing equipment require improved system level cooling. |
• | Systems: Denser racks of equipment are dissipating more heat per unit area. |
• | Facilities: Heat management capacity of data center and telecom facilities are pushing the limits of current air cooling technologies. |
• | Growth: There are currently 4.1 GW of new data centers planned. |
TABLE OF CONTENTS
• | Total Cost of Ownership Savings: Cooling accounts for approximately 40% of a data center’s energy consumption. |
• | Space Savings: Accelsius allows data centers to densify, increasing the number of servers per rack, increasing the number of racks per unit area of data center, and increasing revenue for a given data center footprint and reducing costs as less space is used. |
• | Energy Savings: Eliminates air conditioning needs and costs associated with legacy air-cooling systems. |
• | Water Savings: Potential to eliminate water use in cooling system. |
• | Enables the adoption of high wattage processors. The American Society of Heating, Refrigerating and Air-Conditioning Engineers has suggested that the exponential increase of CPU and GPU wattages is expected to soon exceed the capacity of most existing air cooling systems. |
• | Dramatically improves density in the data center. With Accelsius’ technology, air heat syncs are not required, allowing more processing power in each server. Racks no longer must be depopulated to allow air flow, nor are cold and hot aisles needed. |
• | Allows more power to be allocated to computing rather than cooling. An average data center allocates around 40% of their power to cooling and other overhead. When power used for cooling is reduced, more incoming power for data centers can be used for computing tasks, and data center capacity can be increased dramatically. We estimate that we can reduce the power allocated to cooling by around 49%. |
• | Is compatible with legacy infrastructure. Although new data center builds will prioritize liquid cooling, brownfield sites are still actively introducing AI / machine learning and other dense workloads. Accelsius technology can fit in a standard rack and connect to existing facility water loops. |
• | Heat removal head room. We believe Accelsius technology will be designed to support not just this generation of processors, but many more to come. Standard CPU power consumption is expected to exceed 500 W and standard GPU power consumption is expected to exceed 700 W by the end of 2025, with high performance GPUs reaching 2000 watts in 2026. Based on the recent trajectory of increasing CPU and GPU power consumption, we believe there is a high likelihood that chips may reach temperatures of up to 2500 watts in the near future. The ability to cool these power processors helps protect the investment in Accelsius’ NeuCool technology. |
TABLE OF CONTENTS
• | Expensive (~$100,000 per tank) and with limited thermal headroom (< 50 KW); |
• | Requires modification (re-layout) of server internals for liquid flow and server warranty is usually void; |
• | Servicing requires removal of servers from sealed liquid cooling baths and is time consuming and expensive; |
TABLE OF CONTENTS
• | Forklift upgrade of existing rack infrastructure and inefficient use of real estate; and |
• | Leading competitors include LiquidStack, Green Revolution Cooling, and TMGCore. |
• | Very expensive (~$175,000 per tank); |
• | Vapor can get trapped in the servers causing localized hot spots; |
• | Very few pilot implementations are expanded on because “no one wants tanks full of perfluoroalkyl and polyfluoroalkyl substances coolant in the data center;” and |
• | Leading competitors include LiquidStack, TMGCore and Submer. |
• | Water leaks that can cause catastrophic failure in servers and are the most significant risk. Users state that water leaks around electronic components have occurred and destroyed the servers: “Not a question of ‘if’ it will leak, but ‘when’ it will leak”; |
• | Bio-fouling (biofilm build up) within pipes and cold plates is a concern; |
• | Cooling higher thermal densities requires large pumps and high pressure/flow rate of water (increasing chance of leaks & electricity use); and |
• | Leading competitors include CoolIT Systems and STULZ. |
3 | Not recyclable in all communities. Check locally. |
TABLE OF CONTENTS
• | Package Circularity: AeroFlexx packaging can incorporate up to 50% recycled content without compromise. |
• | Life Cycle Analysis: By considering source reduction, recycled content, recyclability and eliminating excess packaging material in e-commerce, AeroFlexx can deliver up to 83% less waste to landfills, 69% GHG reduction, and 73% less water use. |
• | UN Sustainable Goals Alignment: AeroFlexx can contribute to meeting several of the sustainable development goals outlined by the United Nations, including industry, innovation, and infrastructure; responsible consumption and production; climate action; and life below water. |
• | GHG emissions reduction relative to plastic waste incineration or pyrolysis: Internal LCA analysis indicated about - 400 kg CO2-eq/tonne plastic waste for the Refinity fluidized bed conversion process compared to 1777 kg CO2-eq/tonne plastic waste for incineration and 739 kg CO2-eq/tonne plastic waste for pyrolysis, so Refinity believes that its process will reduce GHG emissions. |
TABLE OF CONTENTS
• | Fossil source reduction: If all plastic waste from landfill and incineration (240 million tonnes per year) were converted to hydrocarbon liquids (e.g., naphtha substitute) at yields consistent with what Refinity believes are possible in the fluidized bed process, those hydrocarbon liquids could replace up to 80% of fossil naphtha; saving roughly 96 million tonnes per year of CO2-eq emissions. |
• | Reduces Complexity of Sourcing: AeroFlexx ships as a flat pak and replaces the bottle, cap and label that customers must procure from multiple sources and destinations. |
• | Reduced Transportation Cost and Footprint: prior to filling the package, shipping as a flat pak creates a form factor that takes up less than 10% of the space in shipping of an equivalent pre-formed empty rigid bottle, in addition to eliminating the need for cap and label supply chains. This reduces cost and environmental footprint by taking trucks off the road. |
• | Lowers Warehouse Requirements and Inventory Cost: with the AeroFlexx flat pak replacing pre-formed empty bottles, caps and labels, there is an overall reduction in the need for inventory space and overall cost associated with labor and working capital. |
• | ISTA-6 Amazon Approved: for shipping liquids via the e-commerce channel, reductions in damages from breakage, leakage and handling can generate significant savings through lower returns or refund rates and reduced overall package and labor costs. |
• | Omni-Channel Ready: the pak is omni-channel ready as soon as it is filled with liquid product from the AeroFlexx filling machine, which we expect to eliminate stock keeping unit proliferation based on desired sales distribution channel. |
• | New Size/Shape Development Efficiency: flexible manufacturing eliminates the need for capital intensive molds and tooling costs, which may enable rapid adoption at a much lower cost. |
• | Product Safety: designed with hygiene in mind with tamper proof packaging that eliminates the use of a discrete closure with AeroFlexx proprietary integrated valve (e.g., no need for a separate cap, pump or package sealing and dispensing device) to help keep products safe and prevent product losses. |
• | Enable higher yield conversion of plastic waste to olefin gases and hydrocarbon liquids. VTT has demonstrated that the fluidized bed process converts plastic waste to olefin gases at higher yield than conventional pyrolysis processes, potentially enabling two to three times higher productivity when the fluidized bed process feeds olefin gases directly to petrochemical steam cracker operations. |
• | Allow use of low cost, mixed plastic wastes. Unlike incumbent recycling processes which typically require more sorting and pre-cleaning of plastic wastes, Refinity believes that the fluidized bed process will be more robust to minimally-sorted, mixed plastic waste streams. |
• | Enable plant site flexibility. We believe that the Refinity fluidized bed operating conditions can be tuned to allow for production of either olefin (ethylene and propylene) gases and hydrocarbon liquids. We believe the flexibility to site and build a liquids plant close to low-cost plastic waste feedstock sources will allow Refinity to minimize transportation costs for plastic waste and reduce operating costs. Refinity expects to site an olefin gas plant adjacent to petrochemical steam cracker operations to take advantage of existing site infrastructure and product purification while also minimizing cost for transporting the olefin product. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | our Class II directors are David Yablunosky, James O. Donnally and Bruce Brown, and their terms will expire at the annual meeting of stockholders to be held in 2026; |
• | our Class III directors are Michael Otworth, Suzanne Niemeyer and Elizabeth Williams, and their terms expire at the annual meeting of stockholders to be held in 2027; and |
• | our Class I directors are Gregory W. Haskell, Daniel J. Hennessy and Michael Amalfitano, and their terms will expire at the annual meeting of stockholders to be held in 2028. |
TABLE OF CONTENTS
• | up to seven (7) directors, so long as the Founding Investors beneficially own greater than 70% of the outstanding shares of Common Stock; |
• | up to six (6) directors, so long as the Founding Investors beneficially own more than 50%, but less than 70%, of the outstanding shares of Common Stock; |
• | up to four (4) directors, so long as the Founding Investors beneficially own at least 40%, but less than 50%, of the outstanding shares of Common Stock; |
• | up to three (3) directors, so long as the Founding Investors beneficially own at least 20%, but less than 40%, of the outstanding shares of Common Stock; and |
• | up to two (2) director, so long as the Founding Investors beneficially own at least 5%, but less than 20%, of the outstanding common shares of the Company. |
TABLE OF CONTENTS
Committee Assignments | |||||||||||||||||||||||||||
Donnally | Brown | Williams | Hennessy | Amalfitano | Haskell* | Yablunosky* | Otworth* | Niemeyer* | |||||||||||||||||||
Audit | C | X | X | ||||||||||||||||||||||||
Compensation | X | C | X | ||||||||||||||||||||||||
N&CG | X | X | C | ||||||||||||||||||||||||
* | Not independent |
TABLE OF CONTENTS
• | Gregory W. (Bill) Haskell, Chief Executive Officer and Manager; |
• | Mike Otworth, Executive Chairman; and |
• | Dr. John Scott, Chief Strategy Officer. |
Name and Principal Position | Fiscal Year | Salary ($)(1) | Bonus ($)(2) | Stock Awards ($)(3) | Option Awards ($)(4) | Non-Equity Incentive Plan Compensation ($) | All Other Compensation ($)(5) | Total ($) | ||||||||||||||||
Gregory W. (Bill) Haskell | 2024 | 300,000 | 2,500,000 | — | — | — | 13,800 | 2,813,800 | ||||||||||||||||
Chief Executive Officer | 2023 | 300,000 | 180,000 | — | — | — | 12,000 | 492,000 | ||||||||||||||||
Mike Otworth | 2024 | 300,000 | — | 7,001,001 | 7,577,786 | — | — | 14,878,787 | ||||||||||||||||
Executive Chairman(6) | 2023 | 300,000 | 180,000 | — | — | — | — | 480,000 | ||||||||||||||||
Dr. John Scott | 2024 | 300,000 | — | 4,100,005 | 6,935,489 | — | — | 11,335,494 | ||||||||||||||||
Chief Strategy Officer(7) | 2023 | 300,000 | 180,000 | — | — | — | — | 480,000 | ||||||||||||||||
(1) | The amount in this column for 2024 for Mr. Haskell represents base salary earned during 2024. For Dr. Scott, the amount represents payments to Corporate Development Group LLC (a company 100% owned by Dr. Scott) with respect to Dr. Scott’s consulting services to Innventure during 2024. For Mr. Otworth, the amount in this column for 2024 represents payments to Sugar Grove Ventures, LLC (a company 100% owned by Mr. Otworth) with respect to Mr. Otworth’s consulting services to Innventure for 2024. |
(2) | The amount in this column for Mr. Haskell in 2024 represents a transaction bonus earned in connection with the Business Combination. |
(3) | The amounts in this column reflect the aggregate grant date fair value of service-based RSUs granted by the Company to the NEOs in 2024 and, with respect to Mr. Otworth, the amount includes the aggregate grant date fair value of the Accelsius Incentive Units (as defined below) granted by Accelsius to him in 2024, each calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic 718. For information regarding the assumptions used in calculating the value of these awards, see Note 14 to the consolidated financial statements included elsewhere in this prospectus. For more information regarding the awards disclosed in this column, see “2024 Equity-Based Compensation” below. The Refinity Incentive Units (as defined below) discussed in such section had an aggregate grant date fair value of $0. |
(4) | The amounts in this column reflect the aggregate grant date fair values of option awards and stock appreciation right awards (“SARs”) granted by the Company to the NEOs in 2024, each calculated in accordance with FASB ASC Topic 718. For information regarding the assumptions used in calculating the value of these awards, see Note 14 to the consolidated financial statements included elsewhere in this prospectus. For more information regarding the awards disclosed in this column, see “2024 Equity-Based Compensation” below. |
TABLE OF CONTENTS
(5) | The amount in this column represents matching contributions provided by Innventure under the 401(k) Plan (as defined and described below). |
(6) | Mr. Otworth provided services to Innventure in a consulting capacity during 2024 through a contract between Innventure LLC and Sugar Grove Ventures, LLC. |
(7) | Dr. Scott provided services to Innventure in a consulting capacity during 2024 through a contract between Innventure LLC and Corporate Development Group LLC, pursuant to which Dr. Scott, the founder and principal of Corporate Development Group LLC, provided strategic guidance and consulting services to Innventure. |
NEO | 2024 Base Salary/Service Fee Rate | ||
Gregory Haskell | $300,000 | ||
Mike Otworth | $300,000 | ||
Dr. John Scott | $300,000 | ||
2024 Bonus Goal | Weighting | Goal Achieved? (yes or no) | ||||
Formation of a new (4th) operating company | 25% | Yes | ||||
Complete the Business Combination with more than $20 million of net proceeds | 50% | Yes | ||||
Meeting each of the following milestones (or a achieving a certain threshold share price): | ||||||
• Formation of a new (4th) operating company | 10% | Yes | ||||
• $10 million of booked revenue for Accelsius | 10% | No | ||||
• $15 million of GAAP revenue for AeroFlexx | 5% | No | ||||
TABLE OF CONTENTS
NEO | RSUs | Options* | ||||
Gregory Haskell | — | — | ||||
Mike Otworth | 537,705 | 262,295 | ||||
Dr. John Scott | 336,066 | 163,934 | ||||
* | The options set forth in the table above were granted with an exercise price of $12.20, the closing stock price on the date of grant. |
TABLE OF CONTENTS
Name | Grant Date | Number of securities underlying the award | Exercise price of the award ($/Sh) | Grant date fair value of the award | Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information | ||||||||||
Gregory Haskell, CEO | — | — | — | — | — | ||||||||||
Mike Otworth, Executive Chairman | 12/9/2024 | 262,295 | 12.20 | $1,712,786 | (0.88)% | ||||||||||
Dr. John Scott, Chief Strategy Officer | 12/9/2024 | 163,934 | 12.20 | $1,070,489 | (0.88)% | ||||||||||
TABLE OF CONTENTS
Name | Type of Award(1) | Option Awards | Stock Awards | ||||||||||||||||||
Number of Securities Underlying Unexercised Options (#) Exercisable | Number of Securities Underlying Unexercised Options (#) Unexercisable | Option Exercise Price ($) | Option Expiration Date | Number of Shares or Units of Stock That Have Not Vested (#) | Market Value of Shares or Units of Stock That Have Not Vested ($) | ||||||||||||||||
Gregory W. (Bill) Haskell | Refinity Units | — | — | — | — | 109,000(4) | — | ||||||||||||||
Mike Otworth | INV Options | — | 262,295(2) | 12.20 | 12/9/2034 | ||||||||||||||||
Refinity Units | 109,000(4) | — | |||||||||||||||||||
Accelsius SARs | — | 150,000(3) | 12.175 | 12/31/2026 | |||||||||||||||||
INV RSUs | 537,705(5) | 7,447,214 | |||||||||||||||||||
Accelsius Units | 75,000(6) | 3,147,750(7) | |||||||||||||||||||
Dr. John Scott | INV Options | — | 163,934(2) | 12.20 | 12/9/2034 | ||||||||||||||||
Refinity Units | 109,000(4) | — | |||||||||||||||||||
Accelsius SARs | — | 150,000(3) | 12.175 | 12/31/2026 | |||||||||||||||||
INV RSUs | 336,066(5) | 4,654,514 | |||||||||||||||||||
Accelsius Units | — | — | — | — | 9,375(8) | 434,813(7) | |||||||||||||||
(1) | Type of Award: Refinity Units – Refinity Incentive Units; INV Options – stock options to purchase shares of Common Stock; INV RSUs – RSUs settled in shares of Common Stock; Accelsius SARs – awards granted by Innventure and settled in shares of Common Stock, the value of which is determined based on the increase in value of Class A Common Units of Accelsius; Accelsius Units – Accelsius Incentive Units. |
(2) | These stock options vested on October 2, 2025. |
(3) | In general, these Accelsius SARs will be automatically exercised upon the earliest to occur of: (i) the 24-month anniversary of the grant date, (ii) the participant’s death, or (iii) the participant’s “disability” (as defined in the applicable award agreement). |
(4) | On December 11, 2024, Refinity Holdings granted to each NEO 109,000 Refinity Incentive Units, with a Refinity Distribution Threshold of $0.00. Such Refinity Incentive Units will vest over a three-year period, with 25% vesting on the one-year anniversary of the grant date and 9.375% vesting quarterly thereafter. |
(5) | These RSUs vested on October 2, 2025. |
(6) | On March 22, 2024, Accelsius granted to Mr. Otworth 100,000 Accelsius Incentive Units, with an Accelsius Distribution Threshold of $4.41. In general, these Accelsius Incentive Units were originally scheduled to vest over a three-year period, with 25% vesting on the grant date and 9.375% vesting quarterly beginning on the one-year anniversary of the grant date, subject to Mr. Otworth’s continued service to Accelsius or one of its subsidiaries. However, as noted above, on August 11, 2025, each of the Compensation Committee and the Accelsius board of directors approved the acceleration and vesting of the then-unvested portion of Mr. Otworth’s Accelsius Incentive Units effective as of August 14, 2025. |
(7) | Because Accelsius was not publicly traded during 2024, these amounts represent the estimated market value of the unvested Accelsius Incentive Units held by each of the NEOs as of December 31, 2024, as more fully described above under the heading “2024 Equity-Based Compensation,” based on an external valuation dated as of December 31, 2024. |
(8) | On May 5, 2022, Accelsius granted to Dr. Scott 100,000 Accelsius Incentive Units, with an Accelsius Distribution Threshold of $0.00. Such Accelsius Incentive Units were 25% vested on the date of grant, and the remainder of the Accelsius Incentive Units vest in eight substantially equal quarterly installments beginning 12 months after the date of grant. For a discussion of the treatment of the NEOs’ Incentive Units in the Business Combination, see “Incentive Units Granted in Prior Years” above. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | Initial Equity Grant: Each non-management director that became a member of our Board as of the Closing Date and who was still serving on our Board on the third business day following the effective date of the Director Compensation Plan received RSUs with a targeted value of $90,000 on such date, in respect of their service from the Closing and the date of the Company’s first annual meeting of stockholders. Such RSUs vested on the date of our 2025 annual meeting of stockholders, subject to each non-management director providing service on our Board through such date. |
• | Quarterly cash retainer: Each non-management director will receive an annual cash retainer fee of $80,000, paid in arrears on a quarterly basis. The annual cash retainer fee will be prorated in the event that a non-management director serves on our Board for a portion of any calendar quarter. |
• | Annual equity retainer: On the date of each of our regularly scheduled annual meetings of stockholders, each non-management director will receive a grant of RSUs with a targeted value of $120,000, which will generally vest on the earlier of (i) the first anniversary of the grant date and (ii) the next annual meeting of stockholders that occurs following the grant date, subject to each non-management director providing service on our Board on such vesting date. If a non-management director is elected to our Board other than in connection with an annual meeting of stockholders, such non-management director’s annual equity retainer will be prorated based on the number of days of service until the scheduled date of the next annual meeting of stockholders. |
• | Committee retainers: Each non-management director who serves as the chairperson of a standing committee of our Board will receive an annual cash retainer fee of $20,000, paid in arrears on a quarterly basis and prorated in the event that such non-management director serves in such position for a portion of any calendar quarter. Each non-management director who serves as a member, but not a chairperson, of a committee of our Board will receive an annual cash retainer fee of $10,000 for each committee, paid in arrears on a quarterly basis and prorated in the event that such non-management director serves in such position for a portion of any calendar quarter. |
TABLE OF CONTENTS
Name | Fees earned or paid in cash ($) | Stock awards ($)(1) | Option awards ($)(2) | Total ($) | ||||||||
James Donnally | 27,500 | 89,999 | 782,000 | 899,499 | ||||||||
Bruce Brown | 27,500 | 89,999 | — | 117,499 | ||||||||
Elizabeth Williams | 25,000 | 89,999 | — | 114,999 | ||||||||
Daniel Hennessy | 25,000 | 89,999 | — | 114,999 | ||||||||
Michael Amalfitano | 25,000 | 89,999 | — | 114,999 | ||||||||
(1) | Reflects the grant date fair value of the RSUs, calculated in accordance with FASB ASC Topic 718. For information regarding assumptions used in calculating these values, see Note 14 to the consolidated financial statements included elsewhere in this prospectus. As of December 31, 2024, the non-management directors held the following outstanding stock awards: each of Messrs. Donnally, Brown, Hennessy and Amalfitano and Ms. Williams, 7,377 RSUs. |
(2) | Reflects the grant date fair value of the Accelsius SARs, calculated in accordance with FASB ASC Topic 718. For information regarding assumptions used in calculating these values, see Note 14 to the consolidated financial statements included elsewhere in this prospectus. The Accelsius SARs were granted by Innventure and are settled in shares of Common Stock, the value of which is determined based on the increase in value of Class A Common Units of Accelsius over a base price of $12.175. In general, these Accelsius SARs will be automatically exercised upon the earliest to occur of: (i) the 24-month anniversary of the grant date, (ii) Mr. Donnally’s death, or (iii) Mr. Donnally’s “disability” (as defined in the applicable award agreement). On June 25, 2025, Mr. Donnally entered into a SAR Amendment on substantially the same terms as those described above that apply to Mr. Otworth and Dr. Scott, except that the Share Cap applicable to Mr. Donnally’s Accelsius SARs is 250,000. As of December 31, 2024, Mr. Donnally held 20,000 Accelsius SARs. Mr. Donnally was granted these Accelsius SARs in respect of prior service. |
TABLE OF CONTENTS
• | the amount involved exceeded or exceeds $120; and |
• | any of such company’s directors, executive officers, or holders of more than 5% of its capital stock, or any immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Company Name | Fiscal Year Ended December 31, | |||||
2024 | 2023 | |||||
Accelsius | $126 | 160 | ||||
AeroFlexx | * | * | ||||
ESG Fund | * | * | ||||
Refinity | $539 | * | ||||
* | Less than $120 |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | the Audit Committee shall review the material facts of all related party transactions; |
• | in reviewing any related party transaction, the Audit Committee will take into account, among other factors that it deems appropriate, whether the related party transaction is on terms no less favorable to Innventure than terms generally available in a transaction with an unaffiliated third-party under the same or similar circumstances and the extent of the related party’s interest in the transaction; |
• | in connection with its review of any related party transaction, Innventure shall provide the Audit Committee with all material information regarding such related party transaction, the interest of the related party and any potential disclosure obligations of Innventure in connection with such related party transaction; and |
• | if a related party transaction will be ongoing, the Audit Committee may establish guidelines for Innventure’s management to follow in its ongoing dealings with the related party. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | the number of shares of any series and the designation to distinguish the shares of such series from the shares of all other series; |
• | the voting powers, if any, and whether such voting powers are full or limited in such series; |
• | the redemption provisions, if any, applicable to such series, including the redemption price or prices to be paid; |
• | whether dividends, if any, will be cumulative or noncumulative, the dividend rate of such series, and the dates and preferences of dividends on such series; |
• | the rights of such series upon the voluntary or involuntary dissolution of, or upon any distribution of the assets of, the Company; |
TABLE OF CONTENTS
• | the provisions, if any, pursuant to which the shares of such series are convertible into, or exchangeable for, shares of any other class or classes or of any other series of the same or any other class or classes of stock, or any other security, of the Company or any other corporation or other entity, and the rates or other determinants of conversion or exchange applicable thereto; |
• | the right, if any, to subscribe for or to purchase any securities of the Company or any other corporation or other entity; |
• | the provisions, if any, of a sinking fund applicable to such series; |
• | any other relative, participating, optional, or other special powers, preferences or rights and qualifications, limitations, or restrictions thereof; and |
• | all as may be determined from time to time by the Board and stated or expressed in the resolution or resolutions providing for the issuance of such preferred stock (collectively, a “Preferred Stock Designation”). |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
• | a director or officer for any breach of their duty of loyalty to our company or our stockholder; |
• | a director or officer for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |
• | a director for unlawful payments of dividends or unlawful stock repurchases, or redemptions as provided in Section 174 of the DGCL; |
• | a director or officer for any transaction from which they derived an improper personal benefit; or |
• | an officer in any action by or in the right of Innventure. |
TABLE OF CONTENTS
• | each person known to us to be the beneficial owner of more than 5% of our Common Stock, Series B Preferred Stock, and Series C Preferred Stock; |
• | each of our NEOs and directors; and |
• | all of our executive officers and directors as a group. |
Name and Address of Beneficial Owner | Amount of Common Stock Beneficially Owned | Percentage of Shares of Common Stock | Amount of Series B Preferred Stock Beneficially Owned | Percentage of Shares of Series B Preferred Stock | Amount of Series C Preferred Stock Beneficially Owned | Percentage of Shares of Series C Preferred Stock | ||||||||||||
Directors and Named Executive Officers: | ||||||||||||||||||
Roland Austrup | 863,264 | 1.49% | — | * | — | * | ||||||||||||
James O. Donnally(1) | 4,236,663 | 7.30% | — | * | — | * | ||||||||||||
Gregory W. Haskell | 752,115 | 1.30% | — | * | — | * | ||||||||||||
Michael Otworth(2) | 3,742,902 | 6.45% | — | * | — | * | ||||||||||||
John Scott(3) | 2,581,653 | 4.45% | — | * | — | * | ||||||||||||
David Yablunosky | 173,964 | * | — | * | — | * | ||||||||||||
Suzanne Niemeyer | 141,098 | * | — | * | — | * | ||||||||||||
Bruce Brown | 12,127 | * | — | * | — | * | ||||||||||||
Elizabeth Williams | 7,377 | * | — | * | — | * | ||||||||||||
Daniel J. Hennessy | 1,177,639 | 2.03% | — | * | — | * | ||||||||||||
Michael Amalfitano | 7,377 | * | — | * | — | * | ||||||||||||
All Directors and Executive Officers as a Group (11 Individuals) | 13,691,429 | 23.59% | — | * | — | * | ||||||||||||
Five Percent Holders | ||||||||||||||||||
WE-INN LLC(4) | 9,235,795 | 15.91% | — | * | — | * | ||||||||||||
Ascent Capital Partners LLC(5) | 5,282,828 | 9.10% | — | * | — | * | ||||||||||||
TABLE OF CONTENTS
Name and Address of Beneficial Owner | Amount of Common Stock Beneficially Owned | Percentage of Shares of Common Stock | Amount of Series B Preferred Stock Beneficially Owned | Percentage of Shares of Series B Preferred Stock | Amount of Series C Preferred Stock Beneficially Owned | Percentage of Shares of Series C Preferred Stock | ||||||||||||
CastleKnight Master Fund LP(6) | 3,086,416 | 5.32% | — | — | * | |||||||||||||
Christopher and Donna Corley(7) | 20,396 | * | 10,198 | 30.77% | — | * | ||||||||||||
Dr. Chi Lim(8) | 10,198 | * | 5,099 | 15.38% | — | * | ||||||||||||
Crown Global Life Insurance LTD IRO Separate Account 30286(9) | 100,000 | * | — | * | 50,000 | 33.33% | ||||||||||||
Glockner Family Venture Fund, LP(10) | 4,680,272 | 8.06% | — | * | — | * | ||||||||||||
Javid Mu’az Baksh Living Trust(11) | 20,396 | * | 10,198 | 30.77% | — | * | ||||||||||||
Matthew and Holly Sellers(12) | 15,298 | * | 7,649 | 23.08% | — | * | ||||||||||||
Neil Eichelberger 2021 Irrevocable Trust(13) | 200,000 | * | — | * | 100,000 | 66.67% | ||||||||||||
* | less than 1% |
(1) | Consists of (i) 4,750 shares of Common Stock held by Mr. Donnally; (ii) 1,507,808 shares of Common Stock held by the James O. Donnally Revocable Trust over which Mr. Donnally has sole voting and investment power; and (iii) 2,724,105 shares of Common Stock that may be deemed to be beneficially owned by Mr. Donnally, which shares are held by certain trusts, including (a) 141,659 shares held by the Barbara G. Glockner Trust, for the benefit of Joseph C. Glockner; (b) 141,659 shares held by the Barbara G. Glockner Trust, for the benefit of Michael P. Glockner; (c) 141,659 shares held by the Barbara G. Glockner Trust, for the benefit of Timothy E. Glockner; (d) 747,834 shares held by the Joseph C. Glockner Revocable Trust; (e) 747,834 shares held by Michael P. Glockner Revocable Trust; (f) 747,834 shares held by the Timothy E. Glockner Revocable Trust; (g) 3,964 shares held by the Andrew M. Glockner Revocable Trust; and (h) 51,662 shares held by the Barbara G. Glockner Revocable Trust, each of which has three trustees, Timothy Glockner, James Donnally, and Theresa Laxton, Mr. Donnally’s spouse, with shared voting power. Timothy Glockner has a life estate interest in the Barbara G. Glockner Trust fbo Timothy E. Glockner. The beneficiaries of the Barbara G. Glockner Trust fbo Timothy E. Glockner are the issue of Timothy Glockner. The beneficiaries of the Barbara G. Glockner Trust fbo Joseph C. Glockner are the issue of Joseph C. Glockner. The beneficiaries of the Barbara G. Glockner Trust fbo Michael P. Glockner are the issue of Michael P. Glockner. |
(2) | Consists of (i) 3,480,607 shares of Common Stock held by Mr. Otworth and (ii) 262,295 shares of Common Stock that Mr. Otworth has the right to acquire in connection with the vesting of stock options on October 2, 2025. |
(3) | Consists of (i) 2,417,719 shares of Common Stock held by Dr. Scott and (ii) 163,934 shares of Common Stock that Dr. Scott has the right to acquire in connection with the vesting of stock options on October 2, 2025. |
(4) | Greg Wasson and Kimberly Wasson share voting and investment power over the securities held by WE-INN LLC. The address for WE-INN LLC is 233 N Michigan Avenue, Suite 1410, Chicago, Illinois 60601. |
(5) | Based on information provided by Ascent Capital Partners LLC in a Schedule 13G filed with the SEC on May 22, 2025. Per such Schedule 13G, Ascent Capital Partners LLC has sole voting power over all of such shares and sole dispositive power over all of such shares. The principal business address of Ascent Capital Partners LLC is 16427 N Scottsdale Road, Suite 410, Scottsdale, Arizona 85255. |
(6) | Mr. Aaron Weitman is the Managing Member of CastleKnight Fund GP, LLC, which is the controlling entity of CastleKnight Master Fund LP, and accordingly Mr. Weitman may be deemed to have voting and investment power over the shares. The principal business address of CastleKnight Master Fund LP is 888 Seventh Avenue, 24th Floor, New York, New York 10019. |
(7) | The 10,198 shares of Series B Preferred Stock held by Christopher and Donna Corley are convertible into 20,396 shares of Common Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series B Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed amount and the 10-trading day VWAP of the Common Stock. Mr. Christopher Corley and Mrs. Donna Corley share voting and investment power over the shares. |
(8) | The 5,099 shares of Series B Preferred Stock held by Dr. Chi Lim are convertible into 10,198 shares of Common Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series B Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed amount and the 10-trading day VWAP of the Common Stock. |
(9) | The 50,000 shares of Series C Preferred Stock held by the Crown Global Life Insurance LTD IRO Separate Account 30286 are convertible into 100,000 shares of Common Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series C Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed amount and the 10-trading day VWAP of the Common Stock. Ms. Terria Godwin and Ms. Pauline McGettigan are the controlling persons of Crown Global Life Insurance LTD IRO Separate Account 30286 and share voting and investment power equally such that voting and investment decisions require the affirmative agreement of both persons. |
(10) | Timothy E. Glockner, Joseph C. Glockner, Michael P. Glockner, and James O. Donnally are members of The Glockner Family Venture Fund, LP and share equal voting and investment power over the 4,680,272 shares of Common Stock. |
(11) | The 10,198 shares of Series B Preferred Stock held by the Javid Mu’az Baksh Living Trust are convertible into 20,396 shares of Common Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series B Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed amount and the 10-trading day VWAP of the Common Stock. Mr. Javid Baksh serves as the trustee for the Javid Mu’az Baksh Living Trust and, accordingly, may be deemed to have voting and investment power over the shares. |
TABLE OF CONTENTS
(12) | The 7,649 shares of Series B Preferred Stock held by Matthew and Holly Sellers are convertible into 15,298 shares of Common Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series B Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed amount and the 10-trading day VWAP of the Common Stock. Mr. Matthew Sellers and Mrs. Holly Sellers share voting and investment power over the shares. |
(13) | The 100,000 shares of Series C Preferred Stock held by the Neil Eichelberger 2021 Irrevocable Trust are convertible into 200,000 shares of Common Stock, assuming the maximum number of shares of Common Stock are issued upon conversion of the Series C Preferred Stock pursuant to its terms, which provide that the conversion price be calculated based on the greater of a fixed amount and the 10-trading day VWAP of the Common Stock. Each of Ms. Leigh Waters and Ms. Marjorie Ann Eichelberger serves as a trustee for the Neil Eichelberger 2021 Irrevocable Trust and has sole voting and investment power over the shares such that voting and investment decisions do not require the agreement of both persons. |
TABLE OF CONTENTS
Name of Selling Stockholder | Number of Shares of Common Stock Beneficially Owned Prior to Offering | Maximum Number of Shares of Common Stock to be Sold Pursuant to this Prospectus | Number of Shares of Common Stock Beneficially Owned After Offering | Percent of Common Stock Beneficially Owned After Offering | ||||||||
Convertible Debentures and SEPA | ||||||||||||
YA II PN, Ltd | 3,048,644(1) | 21,000,000(2) | — | * | ||||||||
PIPE Investment | ||||||||||||
Matthew Briggs | 25,000 | 50,000(3) | — | * | ||||||||
CastleKnight Master Fund LP | 4,286,416 | 2,400,000(4) | 3,086,416 | 5.32% | ||||||||
DOMMFT Investments LLC | 50,000 | 100,000(5) | — | * | ||||||||
Edward P. Hoffman | 8,400 | 16,800(6) | — | * | ||||||||
Jacob Mermelstein | 16,000 | 32,000(7) | — | * | ||||||||
TABLE OF CONTENTS
Name of Selling Stockholder | Number of Shares of Common Stock Beneficially Owned Prior to Offering | Maximum Number of Shares of Common Stock to be Sold Pursuant to this Prospectus | Number of Shares of Common Stock Beneficially Owned After Offering | Percent of Common Stock Beneficially Owned After Offering | ||||||||
Erick and Wendi Kuebler | 8,334 | 16,668(8) | — | * | ||||||||
Daivd R. Lipton | 4,167 | 8,334(9) | — | * | ||||||||
Marvin Mermelstein Descendants’ Trust | 50,000 | 100,000(10) | — | * | ||||||||
Rappaport Ventures LLC | 35,000 | 70,000(11) | — | * | ||||||||
Gregory Reyes | 216,000 | 333,334(12) | 49,333 | * | ||||||||
David Schneider | 9,500 | 19,000(13) | — | * | ||||||||
Matthew P. Spain | 41,667 | 83,334(14) | — | * | ||||||||
YELO Investments II LLC | 10,500 | 21,000(15) | — | * | ||||||||
(1) | Consists of up to 3,048,644 shares of Common Stock that may be issued to Yorkville pursuant to the SEPA and upon conversion of the Convertible Debentures issued to Yorkville pursuant to the Purchase Agreements, without exceeding the ownership limitation set forth in the Convertible Debentures. Based on information provided to us, Yorkville acquired the shares being registered hereunder in the ordinary course of business, and at the time of the acquisition of the shares, Yorkville did not have any agreements or understandings with any person to distribute such shares. The business address of Yorkville is c/o Mark Angelo, 1012 Springfield Avenue, Mountainside, New Jersey, 07092. |
(2) | Consists of (i) up to 12,000,000 shares of Common Stock that may be issued upon conversion of the Convertible Debentures issued and to be issued to Yorkville pursuant to the Purchase Agreements and (ii) up to 9,000,000 shares of Common Stock that may be issued to Yorkville pursuant to the SEPA. |
(3) | Consists of (i) 25,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 25,000 shares of Common Stock that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 1985 Fagerness Point Road, Wayzata, Minnesota 55391. |
(4) | Consists of (i) 1,200,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 1,200,000 shares of Common Stock that may be issued upon exercise of the Series A Warrants. Mr. Aaron Weitman is the Managing Member of CastleKnight Fund GP, LLC, which is the controlling entity of the listed Selling Stockholder, and accordingly Mr. Weitman may be deemed to have voting and investment power over the shares. The principal business address of the Selling Stockholder is 888 Seventh Avenue, 24th Floor, New York, New York 10019. |
(5) | Consists of (i) 50,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 50,000 shares of Common Stock that may be issued upon exercise of the Series A Warrants. Mr. Joel Mermelstein is the ultimate controlling person of the listed Selling Stockholder and, accordingly, may be deemed to have voting and investment power over the shares. The business address of the listed Selling Stockholder is 6500 N. Hamlin Ave., Lincolnwood, Illinois 60712. |
(6) | Consists of (i) 8,400 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 8,400 shares of Common Stock that may be issued upon exercise of the Series A Warrants. Based on the information provided to us, the Selling Stockholder acquired the shares being registered hereunder as a personal investment, and at the time of the acquisition of the shares, the Selling Stockholder did not have any agreements or understandings with any person to distribute such shares. The business address of the listed Selling Stockholder is 5950 Sherry Lane, Suite 470, Dallas, Texas 75225. |
(7) | Consists of (i) 16,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 16,000 shares of Common Stock that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 6500 N. Hamlin Ave., Lincolnwood, Illinois 60712. |
(8) | Consists of (i) 8,334 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 8,334 shares of Common Stock that may be issued upon exercise of the Series A Warrants. Mr. Erick Kuebler and Mrs. Wendi Kuebler share voting and investment power over the shares. Based on the information provided to us, the Selling Stockholder acquired the shares being registered hereunder as a personal investment, and at the time of the acquisition of the shares, the Selling Stockholder did not have any agreements or understandings with any person to distribute such shares. The business address of the listed Selling Stockholder is 5950 Sherry Lane, Suite 470, Dallas, Texas 75225. |
(9) | Consists of (i) 4,167 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 4,167 shares of Common Stock that may be issued upon exercise of the Series A Warrants. Based on information provided to us, the Selling Stockholder acquired the shares being registered hereunder as a personal investment, and at the time of the acquisition of the shares, the Selling Stockholder did not have any agreements or understandings with any person to distribute such shares. The business address of the listed Selling Stockholder is 767 3rd Avenue, New York, New York 10017. |
(10) | Consists of (i) 50,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 50,000 shares of Common Stock that may be issued upon exercise of the Series A Warrants. Mr. Marvin Mermelstein serves as the trustee for the listed Selling Stockholder and, accordingly, may be deemed to have voting and investment power over the shares. The business address of the listed Selling Stockholder is 6500 N. Hamlin Ave., Lincolnwood, Illinois 60712. |
(11) | Consists of (i) 35,000 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 35,000 shares of Common Stock that may be issued upon exercise of the Series A Warrants. Mr. Jay Rappaport and Mrs. Corrina Rappaport are the ultimate controlling persons of the listed Selling Stockholder and share voting and investment power over the shares. The business address of the listed Selling Stockholder is 135 S. Carmelina Ave., Los Angeles, CA 90049. |
TABLE OF CONTENTS
(12) | Consists of (i) 166,667 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 166,667 shares of Common Stock that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 5510 West Dry Creek Road, Manhattan, Montana 59741. |
(13) | Consists of (i) 9,500 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 9,500 shares of Common Stock that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 654 Cypress Hills Drive, Encinitas, California 92024. |
(14) | Consists of (i) 41,667 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 41,667 shares of Common Stock that may be issued upon exercise of the Series A Warrants. The business address of the listed Selling Stockholder is 647 Shore Drive, Boynton Beach, Florida 33435. |
(15) | Consists of (i) 10,500 shares of Common Stock issued pursuant to the Subscription Agreements and (ii) 10,500 shares of Common Stock that may be issued upon exercise of the Series A Warrants. Mr. Joel Mermelstein is the ultimate controlling person of the listed Selling Stockholder and, accordingly, may be deemed to have voting and investment power over the shares. The business address of the listed Selling Stockholder is 6500 N. Hamlin Ave., Lincolnwood, Illinois 60712. |
TABLE OF CONTENTS
TABLE OF CONTENTS
• | one percent (1%) of the total number of Common Stock then outstanding; or |
• | the average weekly reported trading volume of Common Stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding twelve months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. |
TABLE OF CONTENTS
• | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; |
• | block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
• | purchases by a broker-dealer as principal and resale by the broker-dealer for its account; |
• | an exchange distribution in accordance with the rules of the applicable exchange; |
• | privately negotiated transactions; |
• | in underwritten transactions; |
• | settlement of short sales; |
• | in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security; |
• | through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; |
• | distribution to members, limited partners or stockholders of Selling Stockholders; |
• | “at the market” or through market makers or into an existing market for the shares; |
• | a combination of any such methods of sale; or |
• | any other method permitted pursuant to applicable law. |
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Audited Consolidated Financial Statements | |||
Report of Independent Registered Public Accounting Firm (BDO USA, P.C.; PCAOB ID# 243) | F-2 | ||
Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-3 | ||
Consolidated Statements of Operations and Comprehensive Income (Loss) for the period October 2, 2024 through December 31, 2024 (Successor), January 1, 2024 through October 1, 2024 (Predecessor) and the year ended December 31, 2023 (Predecessor) | F-5 | ||
Consolidated Statement of Changes in Mezzanine Capital for the period January 1, 2024 through October 1, 2024 (Predecessor) and the year ended December 31, 2023 (Predecessor) | F-6 | ||
Consolidated Statement of Changes in Stockholders’ Equity for the period October 2, 2024 through December 31, 2024 (Successor), January 1, 2024 through October 1, 2024 (Predecessor) and the year ended December 31, 2023 (Predecessor) | F-8 | ||
Consolidated Statements of Cash Flows for the period October 2, 2024 through December 31, 2024 (Successor), January 1, 2024 through October 1, 2024 (Predecessor) and the year ended December 31, 2023 (Predecessor) | F-9 | ||
Notes to Consolidated Financial Statements | F-11-F-51 | ||
Unaudited Consolidated Financial Statements | |||
Condensed Consolidated Balance Sheets as of June 30, 2025 (Unaudited) and December 31, 2024 | F-52 | ||
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three and Six Months ended June 30, 2025 (Successor) and June 30, 2024 (Predecessor) | F-53 | ||
Unaudited Condensed Consolidated Statements of Changes in Unitholders’ Deficit (Predecessor) for the Three and Six Months ended June 30, 2024 | F-54 | ||
Unaudited Condensed Consolidated Statements of Changes in Mezzanine and Stockholders’ Equity (Deficit) (Successor) for the Three and Six Months ended June 30, 2025 | F-55 | ||
Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months ended June 30, 2025 (Successor) and June 30, 2024 (Predecessor) | F-56 | ||
Notes to Condensed Consolidated Financial Statements (Unaudited) | F-58-F-80 | ||
TABLE OF CONTENTS
TABLE OF CONTENTS
Successor | Predecessor | |||||
December 31, 2024 | December 31, 2023 | |||||
Assets | ||||||
Cash, cash equivalents and restricted cash | $11,119 | $2,575 | ||||
Accounts receivable | 283 | — | ||||
Due from related parties | 4,536 | 2,602 | ||||
Inventories | 5,178 | — | ||||
Prepaid expenses and other current assets | 3,170 | 487 | ||||
Total Current Assets | 24,286 | 5,664 | ||||
Investments | 28,734 | 14,167 | ||||
Property, plant and equipment, net | 1,414 | 637 | ||||
Intangible assets, net | 182,153 | — | ||||
Goodwill | 667,936 | — | ||||
Other assets | 766 | 1,096 | ||||
Total Assets | $905,289 | $21,564 | ||||
Liabilities and Stockholders’ Deficit | ||||||
Accounts payable | $3,248 | $$93 | ||||
Accrued employee benefits | 9,273 | 3,779 | ||||
Accrued expenses | 2,478 | 1,009 | ||||
Related party payables | — | 347 | ||||
Related party notes payable - current | 14,000 | 1,000 | ||||
Notes payable - current | 625 | 912 | ||||
Patent installment payable - current | 1,225 | 775 | ||||
Obligation to issue equity | 4,158 | — | ||||
Warrant liability | 34,023 | — | ||||
Other current liabilities | 317 | 253 | ||||
Total Current Liabilities | 69,347 | 8,168 | ||||
Notes payable, net of current portion | 13,654 | 999 | ||||
Convertible promissory note, net | — | 1,120 | ||||
Convertible promissory note due to related party, net | — | 3,381 | ||||
Embedded derivative liability | — | 1,994 | ||||
Earnout liability | 14,752 | — | ||||
Stock-based compensation liability | 1,160 | — | ||||
Patent installment payable, net of current | 12,375 | 13,075 | ||||
Deferred income taxes | 27,353 | — | ||||
Other liabilities | 355 | 683 | ||||
Total Liabilities | 138,996 | 29,420 | ||||
Commitments and Contingencies (Note 19) | ||||||
Mezzanine Capital | ||||||
Redeemable Class I Units, no par value, 1,000,000 units authorized, issued and outstanding as of December 31, 2023 | — | 2,912 | ||||
Redeemable Class PCTA Units, no par value, 3,982,675 units authorized, issued and outstanding as of December 31, 2023 | — | 7,718 | ||||
Stockholders’ Equity / Unitholders’ Deficit | ||||||
Class B Preferred Units, no par value, 4,639,557 units authorized, and 4,109,961 units issued and outstanding as of December 31, 2023 | — | 38,122 | ||||
Class B-1 Preferred Units, no par value, 2,600,000 units authorized, and 342,608 units issued and outstanding as of December 31, 2023 | — | 3,323 | ||||
TABLE OF CONTENTS
Successor | Predecessor | |||||
December 31, 2024 | December 31, 2023 | |||||
Class A Units, no par value, 10,975,000 units authorized, and 10,875,000 units issued and outstanding as of December 31, 2023 | — | 1,950 | ||||
Class C Units, no par value, 1,585,125 units authorized, and 1,570,125 units issued and outstanding as of December 31, 2023 | — | 844 | ||||
Preferred Stock, $0.0001 par value, 25,000,000 shares authorized, and 1,102,000 shares issued and outstanding as of December 31, 2024 | — | — | ||||
Common Stock, $0.0001 par value, 250,000,000 shares authorized, and 44,597,154 shares issued and outstanding as of December 31, 2024 | 4 | — | ||||
Additional paid-in capital | 502,865 | — | ||||
Accumulated other comprehensive gain (loss) | 909 | — | ||||
Accumulated deficit | (78,262) | (64,284) | ||||
Total Innventure, Inc., Stockholders’ Equity/ Innventure LLC Unitholders’ Deficit | 425,516 | (20,045) | ||||
Non-controlling interest | 340,777 | 1,559 | ||||
Total Stockholders’ Equity/ Unitholders’ Deficit | 766,293 | (18,486) | ||||
Total Liabilities, Mezzanine Capital and Equity | $905,289 | $21,564 | ||||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Revenue | $456 | $764 | $1,117 | ||||||
Operating Expenses | |||||||||
Cost of sales | 3,752 | 777 | — | ||||||
General and administrative | 29,652 | 26,608 | 17,589 | ||||||
Sales and marketing | 2,009 | 4,178 | 3,205 | ||||||
Research and development | 5,340 | 5,978 | 4,001 | ||||||
Total Operating Expenses | 40,753 | 37,541 | 24,795 | ||||||
Loss from Operations | (40,297) | (36,777) | (23,678) | ||||||
Non-operating (Expense) and Income | |||||||||
Interest expense, net | (1,132) | (1,300) | (1,224) | ||||||
Net gain (loss) from investments | — | 11,547 | (6,448) | ||||||
Net (loss) gain on investments - due to related parties | — | (468) | 232 | ||||||
Change in fair value of financial liabilities | (20,946) | (478) | 766 | ||||||
Equity method investment (loss) income | (902) | 893 | (632) | ||||||
Loss on conversion of promissory notes | — | (1,119) | — | ||||||
Write-off of loan commitment fee asset | (10,041) | — | — | ||||||
Miscellaneous other expense | (57) | (64) | — | ||||||
Total Non-operating (Expense) Income | (33,078) | 9,011 | (7,306) | ||||||
Loss before Income Taxes | (73,375) | (27,766) | (30,984) | ||||||
Income tax expense (benefit) | (3,282) | 432 | — | ||||||
Net Loss | (70,093) | (28,198) | (30,984) | ||||||
Less: net loss attributable to Non-redeemable non-controlling interest | (8,339) | (11,762) | (139) | ||||||
Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | (61,754) | (16,436) | (30,845) | ||||||
Basic and diluted loss per share | $(1.41) | ||||||||
Basic and diluted weighted average common shares | 43,951,279 | ||||||||
Other comprehensive income, net of taxes: | |||||||||
Unrealized gain on available-for-sale debt securities - related party | 909 | 62 | — | ||||||
Total other comprehensive loss, net of taxes | 909 | 62 | — | ||||||
Total comprehensive loss, net of taxes | (69,184) | (28,136) | (30,984) | ||||||
Less: comprehensive income attributable to Non-redeemable non-controlling interest | (8,339) | (11,762) | (139) | ||||||
Net Comprehensive Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | $(60,845) | $(16,374) | $(30,845) | ||||||
TABLE OF CONTENTS
Class I Amount | Class PCTA Amount | Total | |||||||
December 31, 2022 | $2,984 | $12,882 | $15,866 | ||||||
Proceeds from capital calls to unitholders | 130 | — | 130 | ||||||
Accretion of redeemable units to redemption value | (202) | (5,164) | (5,366) | ||||||
December 31, 2023 | 2,912 | 7,718 | 10,630 | ||||||
Accretion of redeemable units to redemption value | 1,565 | 10,385 | 11,950 | ||||||
October 1, 2024 | $4,477 | $18,103 | $22,580 | ||||||
TABLE OF CONTENTS
Class B Preferred | Class B-1 Preferred | Class A | Class C | Accumulated Deficit | Accumulated OCI | Non- Controlling Interest | Total Unitholders’ Deficit | |||||||||||||||||
December 31, 2022 (Predecessor) | $20,803 | $3,323 | $1,950 | $639 | $(38,564) | $— | $656 | $(11,193) | ||||||||||||||||
Net loss | — | — | — | — | (30,845) | — | (139) | (30,984) | ||||||||||||||||
Non-controlling interest acquired | — | — | — | — | — | — | 337 | 337 | ||||||||||||||||
Issuance of units, net of issuance costs | 17,319 | — | — | — | — | — | — | 17,319 | ||||||||||||||||
Unit-based compensation | — | — | — | 205 | — | — | 705 | 910 | ||||||||||||||||
Distributions to unitholders | — | — | — | — | (241) | — | — | (241) | ||||||||||||||||
Accretion of redeemable units to redemption value | — | — | — | — | 5,366 | — | — | 5,366 | ||||||||||||||||
December 31, 2023 (Predecessor) | 38,122 | 3,323 | 1,950 | 844 | (64,284) | — | 1,559 | (18,486) | ||||||||||||||||
Net loss | — | — | — | — | (16,436) | — | (11,762) | (28,198) | ||||||||||||||||
Other comprehensive loss, net of taxes | — | — | — | — | — | 62 | — | 62 | ||||||||||||||||
Units issued to non-controlling interest | — | — | — | — | — | — | 13,921 | 13,921 | ||||||||||||||||
Issuance of units, net of issuance costs | 13,561 | — | — | — | — | — | — | 13,561 | ||||||||||||||||
Unit-based compensation | — | — | — | 137 | — | — | 919 | 1,056 | ||||||||||||||||
Issuance of units to non-controlling interest in exchange of convertible promissory notes | — | — | — | — | — | — | 8,443 | 8,443 | ||||||||||||||||
Accretion of redeemable units to redemption value | — | — | — | — | (11,950) | — | — | (11,950) | ||||||||||||||||
October 1, 2024 (Predecessor) | $51,683 | $3,323 | $1,950 | $981 | $(92,670) | $62 | $13,080 | $(21,591) | ||||||||||||||||
TABLE OF CONTENTS
Series B Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Accumulated OCI | Non- Controlling Interest | Total Stockholders’ Equity | |||||||||||||||||||||
Shares | Amount | Shares | Amount | ||||||||||||||||||||||||
October 2, 2024 (Successor) | — | $— | — | $— | $11,342 | $(15,845) | $— | $— | $(4,503) | ||||||||||||||||||
Effect of acquisition of Innventure LLC | — | — | 43,589,850 | 4 | 461,064 | — | — | 343,030 | 804,098 | ||||||||||||||||||
Reclassification of warrants from liability to equity | — | — | — | — | 1,265 | — | — | — | 1,265 | ||||||||||||||||||
Issuance of common shares, net of issuance costs | — | — | 160,000 | — | 2,083 | — | — | — | 2,083 | ||||||||||||||||||
Issuance of preferred shares, net of issuance costs | 1,102,000 | — | — | — | 9,965 | — | — | — | 9,965 | ||||||||||||||||||
Issuance of common shares from warrant exercises | — | — | 259,309 | — | 2,982 | — | — | — | 2,982 | ||||||||||||||||||
Net loss | — | — | — | — | — | (61,754) | — | (8,339) | (70,093) | ||||||||||||||||||
Other comprehensive gain, net of taxes | — | — | — | — | — | — | 909 | — | 909 | ||||||||||||||||||
Non-controlling interest acquired | — | — | — | — | — | — | — | 4,129 | 4,129 | ||||||||||||||||||
Distributions to Stockholders | — | — | — | — | — | (663) | — | — | (663) | ||||||||||||||||||
Vesting of contingent at risk sponsor shares | — | — | 587,995 | — | — | — | — | — | — | ||||||||||||||||||
Stock-based compensation | — | — | — | — | 14,381 | — | — | 1,957 | 16,338 | ||||||||||||||||||
Accrued preferred dividends | — | — | — | — | (217) | — | — | — | (217) | ||||||||||||||||||
December 31, 2024 (Successor) | 1,102,000 | $— | 44,597,154 | $4 | $502,865 | $(78,262) | $909 | $340,777 | $766,293 | ||||||||||||||||||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Cash Flows Used in Operating Activities | |||||||||
Net loss | $(70,093) | $(28,198) | $(30,984) | ||||||
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: | |||||||||
Stock-based compensation | 16,338 | 1,056 | 910 | ||||||
Interest income on debt securities - related party | (106) | (110) | — | ||||||
Change in fair value of financial liabilities | 20,946 | 478 | (766) | ||||||
Change in fair value of payables due to related parties | — | 468 | (232) | ||||||
Write-off of loan commitment fee asset | 10,041 | — | — | ||||||
Non-cash interest expense on notes payable | 248 | 351 | 487 | ||||||
Net (gain) loss on investments | — | (11,547) | 6,448 | ||||||
Equity method investment gain (loss) | 902 | (893) | 632 | ||||||
Loss on conversion of promissory notes | — | 1,119 | — | ||||||
Deferred income taxes | (3,301) | 432 | — | ||||||
Depreciation and amortization | 5,455 | 146 | 8 | ||||||
Payment of patent installment | — | (250) | — | ||||||
Non-cash rent costs | 64 | 185 | 192 | ||||||
Accrued unpaid interest on note payable | 69 | 930 | — | ||||||
Changes in operating assets and liabilities: | |||||||||
Accounts receivable | (166) | (117) | — | ||||||
Prepaid expenses and other current assets | (1,301) | (1,353) | (218) | ||||||
Inventory | (2,354) | (2,824) | — | ||||||
Accounts payable | (11,211) | 6,013 | 9 | ||||||
Accrued employee benefits | 1,656 | 3,838 | 3,181 | ||||||
Accrued expenses | (484) | 674 | 1,230 | ||||||
Stock-based compensation liability | 1,160 | — | — | ||||||
Other current liabilities | (77) | (146) | (155) | ||||||
Obligation to issue equity | 3,000 | 10,920 | — | ||||||
Other assets | — | (20) | (218) | ||||||
Net Cash Used in Operating Activities | (29,214) | (18,848) | (19,476) | ||||||
Cash Flows Provided by (Used in) Investing Activities | |||||||||
Purchase of shares in equity method investee | — | — | (2,000) | ||||||
Contributions to equity method investee | — | — | (130) | ||||||
Investment in debt securities - equity method investee | — | (7,400) | (2,600) | ||||||
Advances to equity method investee | (4,240) | (135) | — | ||||||
Acquisition of property, plant and equipment | (266) | (736) | (645) | ||||||
Acquisition of intangible assets | (30) | — | — | ||||||
Acquisition of net assets, net of cash acquired, through business combination | 16 | — | — | ||||||
Proceeds from sale of investments | — | 2,314 | 708 | ||||||
Cash withdrawn from trust as a result of business combination | 11,342 | — | — | ||||||
Net Cash Provided by (Used in) Investing Activities | 6,822 | (5,957) | (4,667) | ||||||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Cash Flows Provided by Financing Activities | |||||||||
Proceeds from issuance of equity, net of issuance costs | 15,383 | 13,122 | 16,009 | ||||||
Proceeds from the issuance of equity to non-controlling interest, net of issuance costs | 4,169 | 13,859 | 337 | ||||||
Proceeds from the issuance of convertible promissory note | — | — | 2,000 | ||||||
Proceeds from issuance of debt securities, net of issuance costs | 19,455 | — | — | ||||||
Payment of debts | (250) | (540) | (65) | ||||||
Receipt of Capital from Class I Unitholder | — | — | 130 | ||||||
Distributions to Stockholders | (663) | — | (241) | ||||||
Proceeds from the issuance of promissory notes to related parties | — | 12,000 | 1,004 | ||||||
Repayment of promissory note | (4,628) | — | — | ||||||
Cash Flows Provided by Financing Activities | 33,466 | 38,441 | 19,174 | ||||||
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | 11,074 | 13,636 | (4,969) | ||||||
Cash, Cash Equivalents and Restricted Cash Beginning of period | 45 | 2,575 | 7,544 | ||||||
Cash, Cash Equivalents and Restricted Cash End of period | $11,119 | $16,211 | $2,575 | ||||||
Supplemental Cash Flow Information | |||||||||
Cash paid for interest | $991 | $1,070 | $297 | ||||||
Supplemental Disclosure of Noncash Financing Information | |||||||||
Accretion of redeemable units to redemption value | — | 11,950 | 5,366 | ||||||
Debt discount and embedded derivative upon issuance | — | — | 1,119 | ||||||
Issuance of units to non-controlling interest in exchange of convertible promissory notes | — | 7,324 | — | ||||||
Conversion of working capital loans to equity method investees into investments in debt securities - related party | — | 2,600 | — | ||||||
Transfer of liability warrants to equity warrants in the Business Combination | 1,265 | — | — | ||||||
Initial recognition of loan commitment fee | 16,190 | — | — | ||||||
Transfer of loan commitment fee asset | 6,694 | — | — | ||||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Successor | Predecessor | |||||
December 31, 2024 | December 31, 2023 | |||||
Equity-method investments | $17,547 | $4,482 | ||||
Exchange-traded investments at fair value | — | 9,685 | ||||
Investment in debt securities - AFS | 11,187 | — | ||||
Total Investments | $28,734 | $14,167 | ||||
TABLE OF CONTENTS
Successor | Predecessor | |||||||||||
December 31, 2024 | December 31, 2023 | |||||||||||
Asset type | Carrying Amount | Maximum Exposure to Loss | Carrying Amount | Maximum Exposure to Loss | ||||||||
Equity method investment in AeroFlexx | $16,930 | $16,930 | $1,570 | $1,570 | ||||||||
Investments in debt securities - AFS | 11,187 | 11,187 | — | — | ||||||||
Due from related party | 4,472 | 4,472 | 2,600 | 2,600 | ||||||||
Total | $32,589 | $32,589 | $4,170 | $4,170 | ||||||||
ESG Fund | AeroFlexx | |||||||||||
December 31, | December 31, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
Total Assets | $97,445 | $58,022 | $17,002 | $10,780 | ||||||||
Total Liabilities | 93 | 107 | 27,861 | 8,031 | ||||||||
Total Equity (Deficit) | $97,352 | $57,915 | $(10,859) | $2,749 | ||||||||
TABLE OF CONTENTS
ESG Fund | AeroFlexx | |||||||||||
Years ended December 31, | Years ended December 31, | |||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||
Revenue | $202 | $320 | $38 | $16 | ||||||||
Gross (Loss) Profit | (735) | (709) | (57) | 1 | ||||||||
Net Income (Loss) | $39,437 | $(4,557) | $(13,663) | $(8,221) | ||||||||
Amortized cost | Gross unrealized gains | Fair value | |||||||
Investment in Debt Securities - AFS | $10,278 | $909 | $11,187 | ||||||
TABLE OF CONTENTS
Amortized cost | Fair value | |||||
Due within one year | $— | $— | ||||
Due after one year through five years | 10,278 | 11,187 | ||||
Due after five years | — | — | ||||
$10,278 | $11,187 | |||||
December 31, 2024 (Successor) | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | ||||||||
Assets: | ||||||||||||
Investment in debt security - AFS | $— | $— | $11,187 | $11,187 | ||||||||
Liabilities: | ||||||||||||
Earnout liability | $— | $— | $14,752 | $14,752 | ||||||||
WTI warrant liability | 17,230 | 17,230 | ||||||||||
Private placement warrant liability | — | 16,793 | — | 16,793 | ||||||||
December 31, 2023 (Predecessor) | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | ||||||||
Assets: | ||||||||||||
Exchange-traded investments at FVTNI | $9,685 | $— | $— | $9,685 | ||||||||
Liabilities: | ||||||||||||
Embedded derivative liability | $— | $— | $1,994 | $1,994 | ||||||||
Related party payables | 347 | — | — | 347 | ||||||||
TABLE OF CONTENTS
Forward Contract | Embedded Derivative Liability | Investment in debt securities - AFS | Earnout Liability | WTI Warrant Liability | |||||||||||
Balance as of January 1, 2023 (Predecessor) | $— | $1,641 | $— | $— | $— | ||||||||||
Additions | — | 1,119 | — | — | — | ||||||||||
Change in fair value | — | (766) | — | — | — | ||||||||||
Balance as of December 31, 2023 (Predecessor) | $— | $1,994 | $— | $— | $— | ||||||||||
Additions | — | — | 10,110 | — | — | ||||||||||
Settlement | — | (2,472) | — | — | — | ||||||||||
Change in fair value | — | 478 | 62 | — | — | ||||||||||
Balance as of October 1, 2024 (Predecessor) | — | — | 10,172 | — | — | ||||||||||
Balance as of October 2, 2024 (Successor) | — | — | 10,172 | 11,352 | — | ||||||||||
Additions | 54 | — | 106 | 15,690 | |||||||||||
Settlement | (99) | — | — | — | — | ||||||||||
Change in fair value | 45 | — | 909 | 3,400 | 1,540 | ||||||||||
Balance as of December 31, 2024 (Successor) | $— | $— | $11,187 | $14,752 | $17,230 | ||||||||||
TABLE OF CONTENTS
Embedded derivative within 2025 Note issued August 18, 2022 with a principal balance of $4,000 | Settlement | December 31, 2023 | ||||
Discount Rate | 35% | 35% - 36% | ||||
Probability of Expected Outcomes | ||||||
Financing | 100% | 95% | ||||
Change in control | —% | 3% | ||||
Other | —% | 2% | ||||
Embedded derivative within 2025 Notes issued June 7 & July 3, 2023 with an aggregate principal balance of $2,000 | ||||||
Discount Rate | 71% - 87% | 71% - 88% | ||||
Probability of Expected Outcomes | ||||||
Financing | 100% | 95% | ||||
Change in control | —% | 3% | ||||
Other | —% | 2% | ||||
October 2, 2024 | December 31, 2024 | |||||
Volatility | 120.00% | 120.00% | ||||
Time to liquidity | 2 years | 2 years | ||||
Discount for lack of marketability | 18.00% | 31.00% | ||||
Weighted average cost of capital | 45.00% | 45.00% | ||||
Risk-free rate | 3.51% | 4.23% | ||||
TABLE OF CONTENTS
October 2, 2024 | December 31, 2024 | |||||
Term | 7 years | 6.8 years | ||||
Stock price | $10.87 | $13.85 | ||||
Volatility | 56.00% | 56.00% | ||||
Risk-Free Rate | 3.62% | 4.42% | ||||
Dividend Yield | —% | —% | ||||
October 2, 2024 | |||
Revenue risk premium | 6.10% | ||
Revenue volatility | 44.00% | ||
October 2, 2024 | December 31, 2024 | |||||
Revenue risk premium | 30.60% | 36.10% | ||||
Revenue volatility | 165.00% | 176.00% | ||||
TABLE OF CONTENTS
October 22, 2024 | December 31, 2024 | |||||
Stock Price | $11.50 | $13.85 | ||||
Stock Price Volatility | 56.00% | 56.00% | ||||
Credit Spread | 18.60% | 18.80% | ||||
Successor | Predecessor | ||||||||||||||
Maturities | December 31, 2024 | Interest Rates | December 31, 2023 | Interest Rates | |||||||||||
Series 1 promissory notes | 2025 - 2026 | $725 | 12% - 15% | $1,911 | 9% - 15% | ||||||||||
Related party notes | 2024 - 2025 | 14,000 | 8% - 15.99% | 1,000 | —% | ||||||||||
Convertible promissory notes | — | 6,634 | 8% | ||||||||||||
WTI Facility | 2028 | 20,000 | 13.50% | — | |||||||||||
Total Notes Payable | 34,725 | 9,545 | |||||||||||||
Less: unamortized debt discount | (6,446) | (2,133) | |||||||||||||
Less: current portion of related party notes payable | (14,000) | (1,000) | |||||||||||||
Less: current portion of notes payable | (625) | (912) | |||||||||||||
Total Long-term Notes | $13,654 | $5,500 | |||||||||||||
Year Ending December 31, | Amount | ||
2025 | $14,625 | ||
2026 | 7,295 | ||
2027 | 8,244 | ||
2028 | 4,561 | ||
Total Debt | $34,725 | ||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Principal amount | $— | $396 | $1,310 | ||||||
Number of shares | — | 40,829 | 135,133 | ||||||
Successor | Predecessor | ||||||||
Interest Rate | December 31, 2024 | December 31, 2023 | |||||||
Principal amount of 1st extension promissory notes | 12% | $122 | $829 | ||||||
Principal amount of 2nd extension promissory notes | 15% | $603 | $890 | ||||||
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Interest attributable to contractual interest | $29 | $138 | $297 | ||||||
Interest attributable to amortization of issuance costs | — | — | 32 | ||||||
Total interest expense | $29 | $138 | $329 | ||||||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Total interest expense | $611 | $932 | $— | ||||||
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Interest attributable to contractual interest | $— | $120 | $583 | ||||||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Interest attributable to amortization of implied discounts | — | 231 | 456 | ||||||
Total interest expense | $— | $351 | $1,039 | ||||||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Interest attributable to contractual interest | $352 | $— | $— | ||||||
Interest attributable to amortization of issuance costs | 248 | — | — | ||||||
Total interest expense | $600 | $— | $— | ||||||
Successor | Predecessor | |||||
December 31, 2024 | December 31, 2023 | |||||
Raw materials | $2,974 | $— | ||||
Work in process | 50 | — | ||||
Finished goods | 2,154 | — | ||||
Total inventories | $5,178 | $— | ||||
Successor | Predecessor | |||||
December 31, 2024 | December 31, 2023 | |||||
Leasehold improvements | $548 | $38 | ||||
Machinery & equipment | 664 | 86 | ||||
Computers & office equipment | 14 | 19 | ||||
Construction in progress | 266 | 502 | ||||
Property, Plant and Equipment, Gross | 1,492 | 645 | ||||
Less: Accumulated depreciation | (78) | (8) | ||||
Property, Plant and Equipment, Net | $1,414 | $637 | ||||
Successor | Predecessor | ||||||||
Period from October 2, 2024 through December 31, 2024 | Period from January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Depreciation Expense | $78 | $148 | $8 | ||||||
TABLE OF CONTENTS
Innventure LLC Units | Immediately Prior to Closing | Common Stock Conversion Ratio | Common Stock Upon Closing | ||||||
Class B Preferred Units | 10,875,000 | 2.09 | 22,754,664 | ||||||
Class B-1 Preferred Units | 5,609,951 | 2.09 | 11,738,165 | ||||||
Class A Units | 342,608 | 2.09 | 716,867 | ||||||
Class C Units | 1,570,125 | 2.09 | 3,285,303 | ||||||
Total | 18,397,684 | 38,494,999 | |||||||
Learn CW Shares | |||||||||
Learn CW Public shareholders | 1,027,674 | 1.00 | 1,027,674 | ||||||
Learn CW Class B Shareholders | 5,000,000 | 1.00 | 5,000,000 | ||||||
Total | 6,027,674 | 6,027,674 | |||||||
Less: Learn CW shares subject to clawback provisions | (932,823) | ||||||||
Total Common Stock Issued and Outstanding at Closing | 43,589,850 | ||||||||
Holdco Common Stock transferred to Innventure Members(1) | $418,441 | ||
Contingent consideration(2) | 53,980 | ||
Consideration transferred | 472,421 | ||
Non-controlling interest(3) | 343,030 | ||
Total business enterprise value | $815,451 | ||
TABLE OF CONTENTS
(1) | Represents the fair value of the 38,494,999 of aggregate consideration paid in shares (excluding the Company Earnout shares) at a Closing share price of $10.87. |
(2) | Represents the fair value of the Company Earnout Shares issued and contingently issuable to Innventure Members. Refer to Note 10. Earnout Shares for more details. |
(3) | The non-controlling interest represents the fair value of equity in Accelsius held by non-controlling parties. The fair value is calculated using a discounted cash flow methodology to determine the Accelsius equity value which is pro rated by the non-controlling ownership percentage (Level 3). Significant inputs used to measure the fair value of the non-controlling interest include the long-term growth rate of 3%, normalized tax rate of 27.9%, normalized net working capital of 18%, and weighted average cost of capital of 17.6%. |
Amount | |||
Cash consideration transferred | $— | ||
Add: Cash and cash equivalents acquired | 16 | ||
Investing cash flow activity as a result of the Business Combination | $16 | ||
Amount | |||
Cash proceeds from Learn CW trust account | $11,342 | ||
Net cash proceeds from Series B Preferred Stock issuance | 10,572 | ||
Total Innventure, Inc. cash sources | $21,914 | ||
Payment of Learn CW accounts payable and accrued expenses | $9,233 | ||
Payment of Learn CW promissory note due to Sponsor | 4,628 | ||
Payment of Innventure LLC transaction costs at Closing | 6,206 | ||
Total cash uses | $20,067 | ||
Net cash proceeds | $1,847 | ||
Amount | |||
Assets acquired: | |||
Cash and cash equivalents | $16 | ||
Accounts receivable | 117 | ||
Due from related parties | 210 | ||
Inventory | 2,824 | ||
Prepaid expenses and other current assets | 1,955 | ||
Equity method investments | 18,449 | ||
Investment in debt securities - AFS | 10,172 | ||
Property, plant, and equipment | 1,227 | ||
Intangible assets | 187,500 | ||
Other assets | 829 | ||
Total assets acquired: | $223,299 | ||
TABLE OF CONTENTS
Amount | |||
Liabilities assumed: | |||
Accounts payable | $6,286 | ||
Accrued employee benefits | 7,617 | ||
Accrued expenses | 1,972 | ||
Related party payable | 13,932 | ||
Notes payable | 975 | ||
Patent installment payable | 13,600 | ||
Deferred tax liability | 30,654 | ||
Other liabilities | 748 | ||
Total liabilities assumed: | $75,784 | ||
Net identifiable assets acquired | $147,515 | ||
Goodwill | $667,936 | ||
Amount | |||
Trade names | 17,800 | ||
Customer relationships | 4,600 | ||
Developed technology | 165,100 | ||
Total | $187,500 | ||
TABLE OF CONTENTS
December 31, 2024 (Successor) | ||||||||||||
Intangible Asset | Weighted-Average Amortization Period (years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||
Trade names | 16.0 | 17,800 | (277) | 17,523 | ||||||||
Customer relationships | 3.0 | 4,600 | (382) | 4,218 | ||||||||
Developed technology | 9.1 | 165,100 | (4,718) | 160,382 | ||||||||
Other finite-lived intangible assets | 3.0 | 30 | — | 30 | ||||||||
Total intangible assets | $187,530 | $(5,377) | $182,153 | |||||||||
Amortization Expense | |||
2025 | $21,616 | ||
2026 | 21,616 | ||
2027 | 21,234 | ||
2028 | 20,073 | ||
2029 | 18,853 | ||
Thereafter | 78,761 | ||
Total | $182,153 | ||
TABLE OF CONTENTS
• | 40% of the Earnout Shares will vest upon Accelsius having entered into binding contracts providing for revenue for the Company (as defined in the Business Combination Agreement) within 7 years following the Closing (the “Vesting Period”) in excess of $15,000 in revenue (“Milestone One”); |
• | 40% of the Earnout Shares will vest upon the Company’s formation of a new subsidiary, in partnership with an MNC, as determined using the Innventure LLC’s “DownSelect” process, within the Vesting Period (“Milestone Two”); and |
• | 20% of the Earnout Shares will vest upon AeroFlexx having received in excess of $15,000 revenue within the Vesting Period (“Milestone Three”). |
Number of Public Warrants | Number of Private Warrants | Number of WTI Warrants | |||||||
Outstanding, October 2, 2024 (Successor) | 11,499,997 | 7,146,000 | — | ||||||
Exercised | (259,309) | — | — | ||||||
Issued | — | — | 2 | ||||||
Outstanding, December 31, 2024 (Successor) | 11,240,688 | 7,146,000 | 2 | ||||||
TABLE OF CONTENTS
Successor | ||||||||||||
Number of Warrants | Exercise Price | Expiration Date | December 31, 2024 Balance | |||||||||
Private Warrants | 7,146,000 | $11.50 | 10/2/2029 | $16,793 | ||||||||
• | If the WTI Lenders choose to exercise the warrants for Common Stock, the exercise price is $10.00 per share; however, if the volume-weighted average price (VWAP) of the Company’s Common Stock is less than $10.00 per share as of the date which is eighteen months after the Company’s Common Stock began trading, then the exercise price shall be reduced to such lower VWAP. |
• | If the WTI Lenders choose to exercise the warrants for Subsequent Round Stock, the exercise price shall be the lowest price per share paid by any person for the Company’s equity securities issued in a corresponding subsequent round. |
TABLE OF CONTENTS
Successor | ||||||||||||
Number of Warrants | Exercise Price | Expiration Date | December 31, 2024 Balance | |||||||||
WTI Warrants | 2 | varies | 3/31/2025 | $17,230 | ||||||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
Period from October 2, 2024 through December 31, 2024 | Period from January 1 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Compensation expense | $— | $137 | $205 | ||||||
TABLE OF CONTENTS
Number of Shares | Weighted Average Grant Date air Value (per share) | |||||
Granted on December 9, 2024 | 2,036,476 | $12.20 | ||||
Vested | 131,468 | 12.20 | ||||
Forfeited | — | — | ||||
Non-vested at December 31, 2024 | 1,905,008 | $12.20 | ||||
Number of Shares | Weighted Average Exercise Price | Weighted Average Grant Date Fair Value (per share) | |||||||
Granted on December 9, 2024 | 975,409 | $12.20 | $6.63 | ||||||
Vested | 61,560 | 12.20 | 6.63 | ||||||
Exercised | — | — | — | ||||||
Forfeited | — | — | — | ||||||
Outstanding at December 31, 2024 | 913,849 | $12.20 | $6.63 | ||||||
Exercisable at December 31, 2024 | — | — | — | ||||||
TABLE OF CONTENTS
Cash-settled SARs | Stock-settled SARs | |||||||||||||||||
Number of Shares | Weighted Average Exercise Price | Weighted Average Grant Date Fair Value (per share) | Number of Shares | Weighted Average Exercise Price | Weighted Average Grant Date Fair Value (per share) | |||||||||||||
Granted on December 9, 2024 | 30,000 | $12.18 | $38.66 | 320,000 | $12.18 | $38.66 | ||||||||||||
Vested | — | — | — | — | — | — | ||||||||||||
Exercised | — | — | — | — | — | — | ||||||||||||
Forfeited | — | — | — | — | — | — | ||||||||||||
Outstanding at December 31, 2024 | 30,000 | $12.18 | $38.66 | 320,000 | $12.18 | $38.66 | ||||||||||||
Exercisable at December 31, 2024 | — | — | — | — | — | — | ||||||||||||
Successor Period | Predecessor Period | ||||||||
Period from October 2, 2024 through December 31, 2024 | Period from January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Compensation expense | $1,341 | $918 | $705 | ||||||
Class C units granted | 168,500 | 110,000 | 365,500 | ||||||
Weighted average grant date fair value per share | $46.38 | $4.41 | $3.80 | ||||||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Product revenue | $233 | $95 | $— | ||||||
Management fees - related party | 223 | 669 | 892 | ||||||
Consulting revenue | — | — | 225 | ||||||
Total revenue | $456 | $764 | $1,117 | ||||||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Customer A - Related Party | 43.0% | 77.0% | 70.7% | ||||||
Customer B - Related Party | 5.9% | 10.6% | 9.2% | ||||||
Customer C | —% | —% | 20.1% | ||||||
Customer D | —% | 12.4% | —% | ||||||
Customer E | 48.9% | —% | —% | ||||||
Total Revenue Concentration of Major Customers | 97.8% | 100.0% | 100.0% | ||||||
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Current Expense: | |||||||||
Federal | — | — | — | ||||||
State | 18 | — | — | ||||||
Foreign | — | — | — | ||||||
Total Current Expense | 18 | — | — | ||||||
Deferred Expense: | |||||||||
Federal | (3,301) | 432 | — | ||||||
State | — | — | — | ||||||
Foreign | — | — | — | ||||||
Total Deferred Expense | (3,301) | 432 | — | ||||||
Total Expense: | $(3,282) | $432 | $— | ||||||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Pre-tax book loss | $(73,375) | $(27,766) | $(30,984) | ||||||
Income taxes at federal statutory rate | (15,405) | — | — | ||||||
State taxes, net of federal benefit | (1,801) | — | — | ||||||
Tax on pre-tax earnings of corporate subsidiaries | — | (3,022) | (2,229) | ||||||
Warrant liability | 3,685 | — | — | ||||||
Non-deductible expenses | 6 | 6 | 631 | ||||||
Change in earnout fair value | (714) | — | — | ||||||
Other permanent differences | (423) | — | (4) | ||||||
Change in valuation allowance | 11,664 | 3,448 | 1,602 | ||||||
R&D credit | (294) | — | — | ||||||
Total provision (benefit) for income taxes | $(3,282) | $432 | $— | ||||||
December 31, 2024 | December 31, 2023 | |||||
Deferred Tax Assets: | ||||||
Deferred lease liabilities | $138 | $189 | ||||
Capitalized R&D expense | 2,562 | 766 | ||||
Fixed assets and intangibles | 3,113 | 3,614 | ||||
Reserves and other accruals | 4,873 | 178 | ||||
Loss carry-forwards and other tax attributes | 15,682 | 1,663 | ||||
Total Deferred Tax Assets | 26,368 | 6,410 | ||||
Less: Valuation allowance | (11,664) | (5,910) | ||||
Net Deferred Tax Assets | $14,704 | $500 | ||||
Deferred Tax Liabilities: | ||||||
Amortization | $(38,443) | $(323) | ||||
Investment in Partnerships | (3,505) | — | ||||
Right of use assets | (109) | (177) | ||||
Total Deferred Tax Liabilities | (42,057) | (500) | ||||
Net Deferred Tax Liabilities | $(27,353) | $— | ||||
TABLE OF CONTENTS
Successor | |||
October 2, 2024 through December 31, 2024 | |||
Numerator: | |||
Net loss attributable to Innventure, Inc. shareholders | $(61,754) | ||
Less: Cumulative earnings to participating securities | 217 | ||
Undistributed loss for participating securities | (61,971) | ||
Less: Undistributed loss attributable to participating securities | — | ||
Net Loss attributable to common shareholders, basic and diluted | $(61,971) | ||
TABLE OF CONTENTS
Successor | |||
October 2, 2024 through December 31, 2024 | |||
Denominator: | |||
Weighted average number of units outstanding, basic and diluted | 43,951 | ||
Net loss per share attributable to common shareholders, basic and diluted | $(1.41) | ||
Successor | |||
December 31, 2024 | |||
Public warrants | 11,500,000 | ||
Private placement warrants | 7,146,000 | ||
WTI warrants | 1,000,000 | ||
Series B preferred shares | 1,011,869 | ||
Share options | 975,409 | ||
RSUs | 2,036,476 | ||
SARs | 320,000 | ||
TABLE OF CONTENTS
TABLE OF CONTENTS
Years Ending December 31, | Amount | ||
2025 | $1,225 | ||
2026 | 825 | ||
2027 | 825 | ||
2028 | 825 | ||
2029 | 825 | ||
Thereafter | 9,075 | ||
Total | $13,600 | ||
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Revenue from external customers | $233 | $95 | $— | ||||||
Interest income | — | 7 | 14 | ||||||
Cost of sales | $3,752 | $777 | $— | ||||||
Employee costs | 3,933 | 8,076 | 6,849 | ||||||
Facilities, equipment & supplies | 121 | 581 | 499 | ||||||
General and administrative | 751 | 398 | 296 | ||||||
Outside services | 390 | 842 | 844 | ||||||
Research and development | 3,224 | 2,711 | 1,443 | ||||||
Sales and marketing | 193 | 442 | 288 | ||||||
Depreciation expense* | 6 | 99 | 8 | ||||||
Interest expense | 90 | 564 | 1,039 | ||||||
Income tax expense (benefit) | (3,637) | 432 | — | ||||||
Other** | 168 | 1,832 | (635) | ||||||
Total Expenses | $8,991 | $16,754 | $10,631 | ||||||
Net Loss | $(8,758) | $(16,652) | $(10,617) | ||||||
* | Represents depreciation not already included in Cost of sales. |
** | Other - change in fair value of financial liabilities, loss on conversion of promissory notes, travel and other miscellaneous expenses. |
TABLE OF CONTENTS
Successor | Predecessor | ||||||||
October 2, 2024 through December 31, 2024 | January 1, 2024 through October 1, 2024 | Year ended December 31, 2023 | |||||||
Revenues: | |||||||||
Technology | $233 | $95 | $— | ||||||
Other | 250 | 750 | 1,198 | ||||||
Elimination of management services provided to Technology | (27) | (81) | (81) | ||||||
Consolidated Revenues | $456 | $764 | $1,117 | ||||||
Interest Expense: | |||||||||
Technology | $90 | $564 | $1,039 | ||||||
Other | 1,240 | 1,069 | 328 | ||||||
Consolidated Interest Expense | $1,330 | $1,633 | $1,367 | ||||||
Interest Income: | |||||||||
Technology | $— | $7 | $14 | ||||||
Other | 198 | 326 | 129 | ||||||
Consolidated Interest Income | $198 | $333 | $143 | ||||||
Depreciation and Amortization Expense: | |||||||||
Technology | $5,455 | $146 | $8 | ||||||
Other | — | — | — | ||||||
Consolidated Depreciation and Amortization Expense | $5,455 | $146 | $8 | ||||||
Net Loss: | |||||||||
Technology | $(8,758) | $(16,652) | $(10,617) | ||||||
Other | (61,335) | (11,546) | (20,367) | ||||||
Consolidated Net Loss | $(70,093) | $(28,198) | $(30,984) | ||||||
Capital Expenditures: | |||||||||
Technology | $266 | $736 | $645 | ||||||
Other | — | — | — | ||||||
Consolidated Capital Expenditures | $266 | $736 | $645 | ||||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
June 30, 2025 (Unaudited) | December 31, 2024 | |||||
Assets | ||||||
Cash and cash equivalents | $6,965 | $11,119 | ||||
Accounts receivable, net | 901 | 283 | ||||
Due from related parties | 4,188 | 4,536 | ||||
Inventories, net | 6,620 | 5,178 | ||||
Prepaid expenses and other current assets | 2,455 | 3,170 | ||||
Total Current Assets | 21,129 | 24,286 | ||||
Restricted cash | 5,000 | — | ||||
Investments | 32,424 | 28,734 | ||||
Property, plant and equipment, net | 1,972 | 1,414 | ||||
Intangible assets, net | 171,345 | 182,153 | ||||
Goodwill | 323,463 | 667,936 | ||||
Other assets | 652 | 766 | ||||
Total Assets | $555,985 | $905,289 | ||||
Liabilities and Stockholders’ Deficit | ||||||
Accounts payable | $3,710 | $3,248 | ||||
Accrued employee benefits | 10,603 | 9,273 | ||||
Accrued expenses | 2,594 | 2,478 | ||||
Contract liabilities | 690 | — | ||||
Related party notes payable - current | — | 14,000 | ||||
Notes payable - current | 27,502 | 625 | ||||
Embedded derivative liability | 1,796 | — | ||||
Patent installment payable - current | 700 | 1,225 | ||||
Obligation to issue equity | 52 | 4,158 | ||||
Warrant liability | 22,996 | 34,023 | ||||
Income taxes payable | 292 | — | ||||
Related party convertible promissory notes - current | 1,002 | — | ||||
Other current liabilities | 380 | 317 | ||||
Total Current Liabilities | 72,317 | 69,347 | ||||
Notes payable, net of current portion | 11,304 | 13,654 | ||||
Term convertible notes, net of current portion | 2,451 | — | ||||
Related party convertible promissory notes, net of current portion | 3,000 | — | ||||
Earnout liability | 4,370 | 14,752 | ||||
Stock-based compensation liability | 474 | 1,160 | ||||
Patent installment payable, net of current portion | 12,375 | 12,375 | ||||
Deferred income taxes | 23,458 | 27,353 | ||||
Other liabilities | 176 | 355 | ||||
Total Liabilities | 129,925 | 138,996 | ||||
Commitments and Contingencies (Note 16) | ||||||
Stockholders’ Equity | ||||||
Preferred stock, $0.0001 par value, 25,000,000 shares authorized; | ||||||
Series B Preferred Stock, $0.0001 par value, 3,000,000 shares designated, 33,144 and 1,102,000 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | — | — | ||||
Series C Preferred Stock, $0.0001 par value, 5,000,000 shares designated, 150,000 and — shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | — | — | ||||
Common Stock, $0.0001 par value, 250,000,000 shares authorized, 55,221,494 and 44,597,154 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 6 | 4 | ||||
Additional paid-in capital | 525,346 | 502,865 | ||||
Accumulated other comprehensive (loss) gain | (1,289) | 909 | ||||
Accumulated deficit | (305,512) | (78,262) | ||||
Total Innventure, Inc., Stockholders’ Equity | 218,551 | 425,516 | ||||
Non-controlling interest | 207,509 | 340,777 | ||||
Total Stockholders’ Equity | 426,060 | 766,293 | ||||
Total Liabilities and Stockholders’ Equity | $555,985 | $905,289 | ||||
TABLE OF CONTENTS
Three months ended | Six months ended | |||||||||||
June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||
Revenue | $476 | $223 | $700 | $447 | ||||||||
Operating Expenses | ||||||||||||
Cost of sales | 2,861 | — | 3,045 | — | ||||||||
General and administrative | 18,569 | 8,379 | 38,245 | 16,283 | ||||||||
Sales and marketing | 2,208 | 1,366 | 4,304 | 2,549 | ||||||||
Research and development | 6,068 | 1,764 | 12,321 | 3,433 | ||||||||
Goodwill impairment | 113,344 | — | 346,557 | — | ||||||||
Total Operating Expenses | 143,050 | 11,509 | 404,472 | 22,265 | ||||||||
Loss from Operations | (142,574) | (11,286) | (403,772) | (21,818) | ||||||||
Non-operating (Expense) and Income | ||||||||||||
Interest expense, net | (2,647) | (43) | (4,185) | (448) | ||||||||
Net gain (loss) on investments | — | (790) | — | 4,399 | ||||||||
Net gain (loss) on investments – due to related parties | — | 26 | — | (160) | ||||||||
Change in fair value of financial liabilities | 7,176 | — | 23,605 | (478) | ||||||||
Equity method investment (loss) income | (1,924) | 779 | (8,680) | 784 | ||||||||
Realized gain on conversion of available for sale investment | — | — | 1,507 | — | ||||||||
Loss on extinguishment of debt | (3,462) | — | (3,462) | — | ||||||||
Loss on extinguishment of related party debt | — | — | (3,538) | — | ||||||||
Loss on conversion of promissory notes | — | — | — | (1,119) | ||||||||
Miscellaneous other expense | (64) | — | (43) | — | ||||||||
Total Non-operating (Expense) Income | (921) | (28) | 5,204 | 2,978 | ||||||||
Loss before income taxes | (143,495) | (11,314) | (398,568) | (18,840) | ||||||||
Income tax benefit | (2,220) | — | (3,619) | — | ||||||||
Net Loss | (141,275) | (11,314) | (394,949) | (18,840) | ||||||||
Less: net loss attributable to Non-redeemable non-controlling interest | (57,048) | (4,026) | (167,725) | (6,333) | ||||||||
Net Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | (84,227) | (7,288) | (227,224) | (12,507) | ||||||||
Basic and diluted loss per share | $(1.60) | $(4.60) | ||||||||||
Basic and diluted weighted average common shares | 52,546,491 | 49,417,092 | ||||||||||
Other comprehensive income, net of taxes: | ||||||||||||
Unrealized gain (loss) on available for sale debt securities - related party | 189 | — | (691) | — | ||||||||
Reclassification of realized gain on conversion of available for sale investments | — | — | (1,507) | — | ||||||||
Total other comprehensive income, net of taxes | 189 | — | (2,198) | — | ||||||||
Total comprehensive loss, net of taxes | (141,086) | (11,314) | (397,147) | (18,840) | ||||||||
Less: comprehensive loss attributable to Non-redeemable non-controlling interest | (57,048) | (4,026) | (167,725) | (6,333) | ||||||||
Net Comprehensive Loss Attributable to Innventure, Inc. Stockholders / Innventure LLC Unitholders | $(84,038) | $(7,288) | $(229,422) | $(12,507) | ||||||||
TABLE OF CONTENTS
Class B Preferred | Class B-1 Preferred | Class A | Class C | Accumulated Deficit | Non- Controlling Interest | Total (Deficit) Equity | |||||||||||||||
December 31, 2023 | $38,122 | $3,323 | $1,950 | $844 | $(64,284) | $1,559 | $(18,486) | ||||||||||||||
Net loss | — | — | — | — | (5,219) | (2,307) | (7,526) | ||||||||||||||
Units issued to non-controlling interest | — | — | — | — | — | 3,503 | 3,503 | ||||||||||||||
Issuance of preferred units, net of issuance costs | 7,566 | — | — | — | — | — | 7,566 | ||||||||||||||
Unit-based compensation | — | — | — | 51 | — | 345 | 396 | ||||||||||||||
Issuance of units to non-controlling interest in exchange of convertible promissory notes | — | — | — | — | — | 8,443 | 8,443 | ||||||||||||||
Accretion of redeemable units to redemption value | — | — | — | — | (4,415) | — | (4,415) | ||||||||||||||
March 31, 2024 | $45,688 | $3,323 | $1,950 | $895 | $(73,918) | $11,543 | $(10,519) | ||||||||||||||
Net loss | — | — | — | — | (7,288) | (4,026) | (11,314) | ||||||||||||||
Units issued to non-controlling interest | — | — | — | — | — | 7,348 | 7,348 | ||||||||||||||
Issuance of preferred units, net of issuance costs | 2,852 | — | — | — | — | — | 2,852 | ||||||||||||||
Unit-based compensation | — | — | — | 45 | — | 248 | 293 | ||||||||||||||
Accretion of redeemable units to redemption value | — | — | — | — | (362) | — | (362) | ||||||||||||||
June 30, 2024 | $48,540 | $3,323 | $1,950 | $940 | $(81,568) | $15,113 | $(11,702) | ||||||||||||||
TABLE OF CONTENTS
Stockholders’ Equity | Mezzanine Equity | ||||||||||||||||||||||||||||||||||||||
Series B Preferred Stock | Series C Preferred Stock | Common Stock | Preferred Stock | ||||||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | Additional Paid-In Capital | Accumulated Deficit | Accumulated OCI | Non- Controlling Interest | Total Stockholders’ Equity | Shares | Amount | |||||||||||||||||||||||||||
December 31, 2024 | 1,102,000 | $— | — | $— | 44,597,154 | $4 | $502,865 | $(78,262) | $909 | $340,777 | $766,293 | — | $— | ||||||||||||||||||||||||||
Net loss | — | — | — | — | — | — | — | (142,997) | — | (110,677) | (253,674) | — | — | ||||||||||||||||||||||||||
Series B Preferred Stock buyback | (5,000) | — | — | — | — | — | (50) | — | — | — | (50) | — | — | ||||||||||||||||||||||||||
Series B Preferred Stock issued for paid-in-kind dividends | 21,808 | — | — | — | — | — | 218 | — | — | — | 218 | — | — | ||||||||||||||||||||||||||
Issuance of common shares, net of issuance costs | — | — | — | — | 161,964 | — | 1,927 | — | — | — | 1,927 | — | — | ||||||||||||||||||||||||||
Vesting of earnout shares | — | — | — | — | 2,344,682 | 1 | 873 | — | — | — | 874 | — | — | ||||||||||||||||||||||||||
Other comprehensive gain, net of taxes | — | — | — | — | — | — | — | — | (2,387) | — | (2,387) | — | — | ||||||||||||||||||||||||||
Conversion of related party notes | — | — | — | — | — | — | — | — | — | — | — | 2,310,848 | 23,109 | ||||||||||||||||||||||||||
Issuance of Series C Preferred Stock, net | — | — | — | — | — | — | — | — | — | — | — | 575,000 | 5,663 | ||||||||||||||||||||||||||
Non-controlling interest issued and related transfers | — | — | — | — | — | — | (26,303) | — | — | 33,249 | 6,946 | — | — | ||||||||||||||||||||||||||
Distributions to Stockholders | — | — | — | — | — | — | — | (26) | — | — | (26) | — | — | ||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | — | — | 4,943 | — | — | 898 | 5,841 | — | — | ||||||||||||||||||||||||||
Accrued preferred dividends | — | — | — | — | — | — | (217) | — | — | — | (217) | — | (44) | ||||||||||||||||||||||||||
March 31, 2025 | 1,118,808 | $— | — | $— | 47,103,800 | $5 | $484,256 | $(221,285) | $(1,478) | $264,247 | $525,745 | 2,885,848 | $28,728 | ||||||||||||||||||||||||||
Net loss | — | — | — | — | — | — | — | (84,227) | — | (57,048) | (141,275) | — | — | ||||||||||||||||||||||||||
Issuance of common shares, net of issuance costs | — | — | — | — | 481,325 | — | 2,625 | — | — | — | 2,625 | — | — | ||||||||||||||||||||||||||
Other comprehensive gain, net of taxes | — | — | — | — | — | — | — | — | 189 | — | 189 | — | — | ||||||||||||||||||||||||||
Non-controlling interest issued and related transfers | — | — | — | — | — | — | 1,036 | — | — | (602) | 434 | — | — | ||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | — | — | 8,494 | — | — | 912 | 9,406 | — | — | ||||||||||||||||||||||||||
Accrued preferred dividends | — | — | — | — | — | — | 198 | — | — | — | 198 | — | 12 | ||||||||||||||||||||||||||
Conversion to Common Stock | (1,085,664) | — | — | — | 7,636,369 | 1 | 27,269 | — | — | — | 27,270 | (2,735,848) | (27,272) | ||||||||||||||||||||||||||
Transfer of Series C Preferred Stock from Mezzanine equity to Stockholders’ equity | — | — | 150,000 | — | — | — | 1,468 | — | — | — | 1,468 | (150,000) | (1,468) | ||||||||||||||||||||||||||
June 30, 2025 | 33,144 | $— | 150,000 | $— | 55,221,494 | $6 | $525,346 | $(305,512) | $(1,289) | $207,509 | $426,060 | $— | $— | ||||||||||||||||||||||||||
TABLE OF CONTENTS
Successor | Predecessor | |||||
Six months ended June 30, 2025 | Six months ended June 30, 2024 | |||||
Cash Flows Used in Operating Activities | ||||||
Net loss | $(394,949) | $(18,840) | ||||
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities: | ||||||
Stock-based compensation | 15,247 | 689 | ||||
Interest income on debt securities - related party | (195) | — | ||||
Change in fair value of financial liabilities | (23,605) | 478 | ||||
Change in fair value of payables due to related parties | — | 160 | ||||
Non-cash interest expense on notes payable | 2,560 | 352 | ||||
Net gain on investments | — | (4,399) | ||||
Equity method investment gain (loss) | 8,680 | (784) | ||||
Realized gain on conversion of available for sale investments | (1,507) | — | ||||
Loss on extinguishment of debt | 3,462 | — | ||||
Loss on extinguishment of related party debt | 3,538 | — | ||||
Loss on conversion of promissory notes | — | 1,119 | ||||
Deferred income taxes | (3,897) | — | ||||
Depreciation and amortization | 11,182 | 69 | ||||
Goodwill impairment | 346,557 | — | ||||
Payment of patent installment | (525) | — | ||||
Other costs | 165 | 123 | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | (618) | — | ||||
Prepaid expenses and other current assets | (3,312) | (965) | ||||
Inventory | (1,442) | (662) | ||||
Accounts payable | 315 | 3,181 | ||||
Accrued employee benefits | 1,330 | 2,803 | ||||
Accrued expenses | 42 | 357 | ||||
Stock-based compensation liability | (686) | — | ||||
Income taxes payable | 292 | — | ||||
Other current liabilities | (78) | (72) | ||||
Contract liabilities | 690 | — | ||||
Net Cash Used in Operating Activities | (36,754) | (16,391) | ||||
Cash Flows Used in Investing Activities | ||||||
Investment in available-for-sale debt securities - equity method investee | (2,708) | — | ||||
Loans to equity method investee | — | (5,035) | ||||
Acquisition of property, plant and equipment | (932) | (706) | ||||
Proceeds from sale of investments | — | 1,364 | ||||
Net Cash Used in Investing Activities | (3,640) | (4,377) | ||||
Cash Flows Provided by Financing Activities | ||||||
Proceeds from issuance of equity, net of issuance costs | 3,675 | 10,037 | ||||
Proceeds from the issuance of equity to non-controlling interest, net of issuance costs | 5,367 | 10,827 | ||||
Proceeds from the issuance of related party convertible promissory notes | 3,999 | — | ||||
Proceeds from the issuance of term convertible notes | 2,451 | — | ||||
Proceeds from issuance of debt securities, net of issuance costs | 27,000 | — | ||||
Payment of debts | (1,176) | (590) | ||||
Distributions to stockholders and other | (76) | — | ||||
Net Cash Flows Provided by Financing Activities | 41,240 | 20,274 | ||||
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash | 846 | (494) | ||||
Cash, Cash Equivalents and Restricted Cash Beginning of period | 11,119 | 2,575 | ||||
Cash, Cash Equivalents and Restricted Cash End of period | $11,965 | $2,081 | ||||
TABLE OF CONTENTS
Successor | Predecessor | |||||
Six months ended June 30, 2025 | Six months ended June 30, 2024 | |||||
Supplemental Cash Flow Information | ||||||
Cash paid for interest | $1,825 | $99 | ||||
Supplemental Disclosure of Noncash Financing Information | ||||||
Accretion of redeemable units to redemption value | — | 4,777 | ||||
Issuance of units to non-controlling interest in exchange of convertible promissory notes | — | 7,324 | ||||
Conversion of working capital loans to equity method investee into investments in debt securities - related party | 4,375 | — | ||||
Extinguishment of debt with Series C Preferred Stock | 14,000 | — | ||||
Contribution of Series C Preferred Stock to equity method investee | 5,783 | — | ||||
Conversion of AFX available-for-sale term loan into equity method investments | 8,757 | — | ||||
Issuance of common stock as repayment of convertible debt | 2,533 | — | ||||
Issuance of stock in exchange for services | 4,095 | — | ||||
Conversion of preferred stock into common stock | 36,910 | — | ||||
Transfer of Series C Preferred Stock from Mezzanine to Stockholders’ equity | 1,468 | — | ||||
Embedded derivative in association with Convertible Debentures | 1,774 | — | ||||
Equity reallocation between non-controlling interest and additional paid-in capital | 25,268 | — | ||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
June 30, 2025 | December 31, 2024 | |||||
Equity-method investments | $23,407 | $17,547 | ||||
Investment in debt securities - AFS | 9,017 | 11,187 | ||||
Total Investments | $32,424 | $28,734 | ||||
TABLE OF CONTENTS
June 30, 2025 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | ||||||||
Assets: | ||||||||||||
Investment in debt security - AFS | $— | $— | $9,017 | $9,017 | ||||||||
Liabilities: | ||||||||||||
Earnout liability | $— | $— | $4,370 | $4,370 | ||||||||
2024 WTI Warrant liability | — | — | 12,450 | 12,450 | ||||||||
2025 WTI Warrant liability | — | — | 3,400 | 3,400 | ||||||||
Private placement warrant liability | — | 7,146 | — | 7,146 | ||||||||
Embedded derivative liability - Convertible Debentures | — | — | 1,796 | 1,796 | ||||||||
December 31, 2024 | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | ||||||||
Assets: | ||||||||||||
Investment in debt security - AFS | $— | $— | $11,187 | $11,187 | ||||||||
Liabilities: | ||||||||||||
Earnout liability | $— | $— | $14,752 | $14,752 | ||||||||
2024 WTI Warrant liability | — | — | 17,230 | 17,230 | ||||||||
Private placement warrant liability | — | 16,793 | — | 16,793 | ||||||||
TABLE OF CONTENTS
Embedded derivative liability - convertible promissory notes | Investment in debt securities - AFS | Earnout liability | 2024 WTI Warrant liability | 2025 WTI Warrant liability | Embedded derivative liability - Convertible Debentures | |||||||||||||
Balance as of January 1, 2024 (Predecessor) | $1,994 | $— | $— | $— | $— | $— | ||||||||||||
Settlement | (2,472) | — | — | — | — | — | ||||||||||||
Change in fair value | 478 | — | — | — | — | — | ||||||||||||
Balance as of June 30, 2024 (Predecessor) | $— | $— | $— | $— | $— | $— | ||||||||||||
Balance as of January 1, 2025 (Successor) | $— | $11,187 | $14,752 | $17,230 | $— | $— | ||||||||||||
Additions | — | 7,278 | — | — | 3,090 | 1,774 | ||||||||||||
Settlement | — | (8,757) | (873) | — | — | — | ||||||||||||
Change in fair value | — | (691) | (9,509) | (4,780) | 310 | 22 | ||||||||||||
Balance as of June 30, 2025 (Successor) | $— | $9,017 | $4,370 | $12,450 | $3,400 | $1,796 | ||||||||||||
Principal Valuation Techniques | Unobservable Inputs | June 30, 2025 | December 31, 2024 | |||||||||
Investment in debt securities - AFS: | ||||||||||||
Black-Scholes model | Volatility | 120% | ||||||||||
Time to liquidity | 2 years | |||||||||||
Discount for lack of marketability | 31.00% | |||||||||||
Weighted average cost of capital | 45.00% | |||||||||||
Risk-free rate | 4.23% | |||||||||||
Discounted Cash Flows | AeroFlexx yield | 13.31% | ||||||||||
Earnout Shares: | ||||||||||||
Geometric Brownian Motion | Term | 6.3 years | 6.8 years | |||||||||
Stock price | $4.80 | $13.85 | ||||||||||
Volatility | 56.00% | 56.00% | ||||||||||
Risk-free rate | 3.87% | 4.42% | ||||||||||
Revenue risk premium | 28.20% | 36.10% | ||||||||||
Revenue volatility | 152.00% | 176.00% | ||||||||||
2024 WTI Warrants: | ||||||||||||
Geometric Brownian Motion | Stock price | $4.80 | $13.85 | |||||||||
Stock price volatility | 56.00% | 56.00% | ||||||||||
Credit spread | 25.60% | 18.80% | ||||||||||
2025 WTI Warrants: | ||||||||||||
Geometric Brownian Motion | Stock price | $4.80 | ||||||||||
Stock price volatility | 56.00% | |||||||||||
Credit spread | 25.60% | |||||||||||
Embedded derivative liability - Convertible Debentures: | ||||||||||||
Discounted Cash Flows | Debt Yield | 40.60% | ||||||||||
TABLE OF CONTENTS
Maturities | June 30, 2025 | Interest Rates | December 31, 2024 | Interest Rates | |||||||||||
Series 1 promissory notes | 2025 - 2026 | $425 | 15% | $725 | 12% - 15% | ||||||||||
Related party notes | — | — | — | 14,000 | 8% - 15.99% | ||||||||||
Convertible debentures | 2026 | 28,172 | —% | — | |||||||||||
Term convertible notes | 2026 | 2,451 | 3.94% | — | |||||||||||
Related party convertible notes | 2025 - 2026 | 4,002 | 3.94% - 15% | — | |||||||||||
WTI Facility | 2028 | 20,000 | 13.50% | 20,000 | 13.50% | ||||||||||
Total Notes Payable | 55,050 | 34,725 | |||||||||||||
Less: unamortized debt discount | (9,791) | (6,446) | |||||||||||||
Less: current portion of related party notes payable | — | (14,000) | |||||||||||||
Less: current portion of related party convertible notes | (1,002) | — | |||||||||||||
Less: current portion of notes payable | (27,502) | (625) | |||||||||||||
Total Long-term Notes | $16,755 | $13,654 | |||||||||||||
TABLE OF CONTENTS
Year Ending December 31, | Amount | ||
2025 (remaining 6 months) | $13,011 | ||
2026 | 29,234 | ||
2027 | 8,244 | ||
2028 | 4,561 | ||
Total Debt | $55,050 | ||
Three months ended | Six months ended | ||||||||||||||
Interest Rate | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||||
Principal amount of 1st extension promissory notes | 12% | $— | $— | $— | $122 | ||||||||||
Principal amount of 2nd extension promissory notes | 15% | $— | $— | $122 | $300 | ||||||||||
Three months ended | Six months ended | |||||||||||
June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||
Interest attributable to contractual interest | $16 | $44 | $48 | $99 | ||||||||
TABLE OF CONTENTS
Three months ended | Six months ended | |||||||||||
June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||
Total interest expense | $— | $— | $419 | $— | ||||||||
TABLE OF CONTENTS
Three months ended | Six months ended | |||||||||||
June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||
Interest attributable to contractual interest | $683 | $— | $1,358 | $— | ||||||||
Interest attributable to amortization of issuance costs and discounts | 348 | — | 856 | — | ||||||||
Total interest expense | $1,031 | $— | $2,214 | $— | ||||||||
TABLE OF CONTENTS
Three months ended | Six months ended | |||||||||||
June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||
Interest attributable to amortization of issuance costs | 1,701 | — | 1,701 | — | ||||||||
Total interest expense | $1,701 | $— | $1,701 | $— | ||||||||
TABLE OF CONTENTS
June 30, 2025 | December 31, 2024 | |||||
Raw materials | $3,560 | $2,974 | ||||
Work in process | 26 | 50 | ||||
Finished goods | 3,034 | 2,154 | ||||
Total inventories | $6,620 | $5,178 | ||||
June 30, 2025 | December 31, 2024 | |||||
Leasehold improvements | $887 | $548 | ||||
Machinery & equipment | 1,524 | 664 | ||||
Computers & office equipment | 14 | 14 | ||||
Construction in progress | — | 266 | ||||
Property, plant and equipment, gross | 2,425 | 1,492 | ||||
Less: Accumulated depreciation | (453) | (78) | ||||
Property, plant and equipment, net | $1,972 | $1,414 | ||||
Balance as of December 31, 2024 | $667,936 | ||
Impairment | (346,557) | ||
Other | 2,084 | ||
Balance as of June 30, 2025 | $323,463 | ||
TABLE OF CONTENTS
June 30, 2025 | December 31, 2024 | ||||||||||||||||||||
Intangible Asset | Weighted-Average Amortization Period Remaining (Years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||
Trade names | 15.3 | 17,800 | (833) | 16,967 | 17,800 | $(277) | $17,523 | ||||||||||||||
Customer relationships | 2.3 | 4,600 | (1,149) | 3,451 | 4,600 | $(382) | $4,218 | ||||||||||||||
Developed technology | 8.5 | 165,100 | (14,198) | 150,902 | 165,100 | $(4,718) | $160,382 | ||||||||||||||
Other finite-lived intangible assets | 2.4 | 30 | (5) | 25 | 30 | — | $30 | ||||||||||||||
Total intangible assets | $187,530 | $(16,185) | $171,345 | $187,530 | $(5,377) | $182,153 | |||||||||||||||
Amortization Expense | |||
2025 (excluding the first six months of fiscal year 2025) | $10,808 | ||
2026 | 21,616 | ||
2027 | 21,234 | ||
2028 | 20,073 | ||
2029 | 18,853 | ||
2030 and thereafter | 78,761 | ||
Total | $171,345 | ||
TABLE OF CONTENTS
Number of Public Warrants | Number of Private Warrants | Number of 2024 WTI Warrants | Number of 2025 WTI Warrants | |||||||||
Outstanding, December 31, 2024 (Successor) | 11,240,688 | 7,146,000 | 2 | — | ||||||||
Exercised | — | — | — | — | ||||||||
Issued | — | — | — | 2 | ||||||||
Outstanding, June 30, 2025 (Successor) | 11,240,688 | 7,146,000 | 2 | 2 | ||||||||
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
Three months ended June 30, 2025 | Six months ended June 30, 2025 | |||||
Numerator: | ||||||
Net loss attributable to Innventure, Inc., shareholders | $(84,227) | $(227,224) | ||||
Less: Cumulative earnings to participating securities | 37 | 42 | ||||
Undistributed loss for participating securities | (84,264) | (227,266) | ||||
Less: Undistributed loss attributable to participating securities | — | — | ||||
Net loss attributable to common shareholders, basic and diluted | $(84,264) | $(227,266) | ||||
Denominator: | ||||||
Weighted average number of units outstanding, basic and diluted | 52,546,491 | 49,417,092 | ||||
Net loss per share attributable to common shareholders, basic and diluted | $(1.60) | $(4.60) | ||||
Three months ended June 30, 2025 | Six months ended June 30, 2025 | |||||
Public warrants | 11,240,688 | 11,240,688 | ||||
Private placement warrants | 7,146,000 | 7,146,000 | ||||
2024 WTI Warrants | 1,000,000 | 1,000,000 | ||||
Convertible Debentures | 2,817,200 | 2,817,200 | ||||
2025 WTI Warrants | 495,074 | 495,074 | ||||
Series B Preferred Stock | 41,762 | 26,516 | ||||
Series C Preferred Stock | 189,000 | 194,062 | ||||
Share options | 1,596,702 | 1,596,702 | ||||
RSUs | 2,148,001 | 2,148,001 | ||||
SARs | 320,000 | 320,000 | ||||
TABLE OF CONTENTS
TABLE OF CONTENTS
Years Ending December 31, | Amount | ||
2025 (excluding the first six months of fiscal year 2025) | $700 | ||
2026 | 825 | ||
2027 | 825 | ||
2028 | 825 | ||
2029 | 825 | ||
Thereafter | 9,075 | ||
Total | $13,075 | ||
TABLE OF CONTENTS
Three months ended | Six months ended | |||||||||||
June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||
Revenue | $254 | $— | $255 | $— | ||||||||
Interest income | — | — | 4 | — | ||||||||
Cost of sales | $2,861 | $— | $3,045 | $— | ||||||||
Employee costs | 3,517 | 2,701 | 7,804 | 5,330 | ||||||||
Facilities, equipment & supplies | 80 | 181 | 461 | 399 | ||||||||
General and administrative | 840 | 143 | 3,235 | 286 | ||||||||
Outside services | 501 | 175 | 809 | 412 | ||||||||
Research and development | 3,678 | 690 | 8,023 | 1,343 | ||||||||
Sales and marketing | 148 | 194 | 432 | 357 | ||||||||
Depreciation expense * | 156 | 64 | 301 | 69 | ||||||||
Interest expense | 190 | 55 | 317 | 491 | ||||||||
Income tax expense (benefit) | (2,645) | — | (4,104) | — | ||||||||
Goodwill impairment | 113,344 | — | 346,557 | — | ||||||||
Other ** | 91 | 106 | 195 | 1,750 | ||||||||
Total Expenses | $122,761 | $4,309 | $367,075 | $10,437 | ||||||||
Net Loss | $(122,507) | $(4,309) | $(366,816) | $(10,437) | ||||||||
* | Represents depreciation expense not already included in Cost of sales. |
** | Other - change in fair value of financial liabilities, loss on conversion of promissory notes, travel and other miscellaneous expenses. |
Three months ended | Six months ended | |||||||||||
June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||
Revenues: | ||||||||||||
Technology | $254 | $— | $255 | $— | ||||||||
Other | 249 | 250 | 499 | 501 | ||||||||
Elimination of management services provided to Technology | (27) | (27) | (54) | (54) | ||||||||
Consolidated Revenues | $476 | $223 | $700 | $447 | ||||||||
TABLE OF CONTENTS
Three months ended | Six months ended | |||||||||||
June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | June 30, 2025 (Successor) | June 30, 2024 (Predecessor) | |||||||||
Interest Expense: | ||||||||||||
Technology | $190 | $55 | $317 | $491 | ||||||||
Other | 2,747 | 44 | 4,382 | 99 | ||||||||
Consolidated Interest Expense | $2,937 | $99 | $4,699 | $590 | ||||||||
Interest Income: | ||||||||||||
Technology | $— | $— | $4 | $— | ||||||||
Other | 290 | 56 | 510 | 142 | ||||||||
Consolidated Interest Income | $290 | $56 | $514 | $142 | ||||||||
Depreciation and Amortization Expense: | ||||||||||||
Technology | $5,629 | $64 | $11,177 | $69 | ||||||||
Other | 5 | — | 5 | — | ||||||||
Consolidated Depreciation and Amortization Expense | $5,634 | $64 | $11,182 | $69 | ||||||||
Net Loss: | ||||||||||||
Technology | $(122,508) | $(4,309) | $(366,817) | $(10,437) | ||||||||
Other | (18,767) | (7,005) | (28,132) | (8,403) | ||||||||
Consolidated Net Loss | $(141,275) | $(11,314) | $(394,949) | $(18,840) | ||||||||
Capital Expenditures: | ||||||||||||
Technology | $15 | $66 | $932 | $706 | ||||||||
Other | — | — | — | — | ||||||||
Consolidated Capital Expenditures | $15 | $66 | $932 | $706 | ||||||||
TABLE OF CONTENTS